{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:44:01Z","timestamp":1794278641336,"version":"4.9.0"},"reference-count":989,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:00:00Z","timestamp":1793750400000},"content-version":"vor","delay-in-days":368,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jacc.2025.05.007","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T06:27:53Z","timestamp":1755239273000},"page":"1567-1678","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":328,"title":["2025 AHA\/ACC\/AANP\/AAPA\/ABC\/ACCP\/ACPM\/AGS\/AMA\/ASPC\/NMA\/PCNA\/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults"],"prefix":"10.1016","volume":"86","author":[{"given":"Daniel W.","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith C.","family":"Ferdinand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra J.","family":"Taler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather M.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daichi","family":"Shimbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwah","family":"Abdalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Martine","family":"Altieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie A.","family":"Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam P.","family":"Bress","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordana B.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen J.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Commodore-Mensah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie L.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent","family":"Egan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadiya S.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald M.","family":"Lloyd-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette Mazurek","family":"Melnyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva A.","family":"Mistry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Modele O.","family":"Ogunniyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey L.","family":"Schott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Sidney C.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy W.","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanpen","family":"Vongpatanasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol E.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul K.","family":"Whelton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff D.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna K.","family":"Arnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Bhalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Billups","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Bowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly B.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"Handberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Wallace Robert","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Ji","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee","family":"Langstaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Jose","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark K.","family":"Santillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prentiss","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer T.","family":"Thibodeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Wozniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Jackson T.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy C.","family":"Ziai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2025.05.007_bib1","series-title":"Clinical Practice Guidelines We Can Trust","year":"2011"},{"key":"10.1016\/j.jacc.2025.05.007_bib2","series-title":"Finding What Works in Healthcare: Standards for Systematic Reviews","article-title":"Committee on Standards for Systematic Reviews of Comparative Effectiveness Research, Institute of Medicine (US)","year":"2011"},{"key":"10.1016\/j.jacc.2025.05.007_bib3","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.jacc.2014.03.016","article-title":"ACC\/AHA statement on cost\/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines","volume":"63","author":"Anderson","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib4","article-title":"Methodology Manual and policies from the ACCF\/AHA Task Force on Practice Guidelines","year":"2010","journal-title":"American College of Cardiology and American Heart Association"},{"key":"10.1016\/j.jacc.2025.05.007_bib5","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.jacc.2015.09.001","article-title":"Further evolution of the ACC\/AHA clinical practice guideline recommendation classification system: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"67","author":"Halperin","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib6","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.jacc.2014.07.012","volume":"64","author":"Arnett","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib7","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.jacc.2019.02.012","article-title":"Recent innovations, modifications, and evolution of ACC\/AHA clinical practice guidelines: an update for our constituencies: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Levine","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib8","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","article-title":"Development and validation of the American Heart Association\u2019s PREVENT equations","volume":"149","author":"Khan","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib9","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1161\/01.cir.0000437740.48606.d1","article-title":"2013 AHA\/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Eckel","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib10","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1016\/j.jacc.2013.11.004","article-title":"2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and The Obesity Society","volume":"63","author":"Jensen","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib11","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.jacc.2019.03.010","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"74","author":"Arnett","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib12","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.jacc.2020.11.018","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"77","author":"Otto","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib13","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib14","doi-asserted-by":"crossref","first-page":"e223","DOI":"10.1016\/j.jacc.2022.08.004","article-title":"2022 ACC\/AHA guideline for the diagnosis and management of aortic disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"80","author":"Isselbacher","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib15","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jacc.2023.04.003","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"83","author":"Virani","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"83","author":"Joglar","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib17","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1016\/j.jacc.2024.02.013","article-title":"2024 ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS guideline for the management of lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"83","author":"Gornik","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib18","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.jacc.2024.06.013","article-title":"2024 AHA\/ACC\/ACS\/ASNC\/HRS\/SCA\/SCCT\/SCMR\/SVM guideline for perioperative cardiovascular management for noncardiac surgery: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"84","author":"Thompson","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib19","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIR.0000000000000232","article-title":"Current science on consumer use of mobile health for cardiovascular disease prevention: a scientific statement from the American Heart Association","volume":"132","author":"Burke","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib20","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1161\/HYP.0000000000000084","article-title":"Resistant hypertension: detection, evaluation, and management: a scientific statement from the American Heart Association","volume":"72","author":"Carey","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib21","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1161\/HYP.0000000000000087","article-title":"Measurement of blood pressure in humans: a scientific statement from the American Heart Association","volume":"73","author":"Muntner","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib22","doi-asserted-by":"crossref","DOI":"10.1161\/HCQ.0000000000000057","article-title":"2019 AHA\/ACC clinical performance and quality measures for adults with high blood pressure: a report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures","volume":"12","author":"Casey","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2025.05.007_bib23","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jacc.2018.10.069","article-title":"Blood pressure assessment in adults in clinical practice and clinic-based research: JACC scientific expert panel","volume":"73","author":"Muntner","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib24","doi-asserted-by":"crossref","first-page":"E42","DOI":"10.1161\/CIR.0000000000000803","article-title":"Self-measured blood pressure monitoring at home: a joint policy statement from the American Heart Association and American Medical Association","volume":"142","author":"Shimbo","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib25","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1161\/HYP.0000000000000217","article-title":"Revascularization for renovascular disease: a scientific statement from the American Heart Association","volume":"79","author":"Bhalla","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib26","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/HYP.0000000000000203","article-title":"Medication adherence and blood pressure control: a scientific statement from the American Heart Association","volume":"79","author":"Choudhry","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib27","doi-asserted-by":"crossref","first-page":"e558","DOI":"10.1161\/CIR.0000000000001107","article-title":"An overview of telehealth in the management of cardiovascular disease: a scientific statement from the American Heart Association","volume":"146","author":"Takahashi","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib28","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1161\/HYP.0000000000000208","article-title":"Hypertension in pregnancy: diagnosis, blood pressure goals, and pharmacotherapy: a scientific statement from the American Heart Association","volume":"79","author":"Garovic","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib29","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1161\/CIR.0000000000001078","article-title":"Life's essential 8: updating and enhancing the American Heart Association's construct of cardiovascular health: a Presidential Advisory from the American Heart Association","volume":"146","author":"Lloyd-Jones","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib30","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.jacc.2023.03.393","article-title":"2023 ACC expert consensus decision pathway on management of heart failure with preserved ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"81","author":"Kittleson","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib31","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a Presidential Advisory from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib32","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/CIR.0000000000001191","article-title":"Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the American Heart Association","volume":"148","author":"Khan","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib33","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1161\/HYP.0000000000000232","article-title":"Implementation strategies to improve blood pressure control in the United States: a scientific statement from the American Heart Association and American Medical Association","volume":"80","author":"Abdalla","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib34","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1161\/HYP.0000000000000240","article-title":"Renal denervation for the treatment of hypertension: a scientific statement from the American Heart Association","volume":"81","author":"Cluett","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib36","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib37","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/S0140-6736(14)60685-1","article-title":"Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people","volume":"383","author":"Rapsomaniki","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib38","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1001\/jamacardio.2020.1731","article-title":"Association of normal systolic blood pressure level with cardiovascular disease in the absence of risk factors","volume":"5","author":"Whelton","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib39","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004248","article-title":"Effectiveness of chlorthalidone plus amiloride for the prevention of hypertension: the PREVER-Prevention randomized clinical trial","volume":"5","author":"Fuchs","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.05.007_bib40","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib41","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","article-title":"Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib42","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2016.19043","article-title":"Global burden of hypertension and systolic blood pressure of atleast 110 to 115 mm Hg, 1990-2015","volume":"317","author":"Forouzanfar","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib43","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1161\/CIR.0000000000001209","article-title":"2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association","volume":"149","author":"Martin","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib44","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1161\/01.CIR.96.1.308","article-title":"Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study","volume":"96","author":"Franklin","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib45","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/jamacardio.2019.0529","article-title":"Lifetime risks for hypertension by contemporary guidelines in African American and White men and women","volume":"4","author":"Chen","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib46","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/HYPERTENSIONAHA.110.168005","article-title":"Ethnic differences in hypertension incidence among middle-aged and older adults: the multi-ethnic study of atherosclerosis","volume":"57","author":"Carson","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib47","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/jama.287.8.1003","article-title":"Residual lifetime risk for developing hypertension in middle-aged women and men: the Framingham Heart Study","volume":"287","author":"Vasan","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib48","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1001\/archinte.159.18.2206","article-title":"Cross-classification of JNC VI blood pressure stages and risk groups in the Framingham Heart Study","volume":"159","author":"Lloyd-Jones","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib49","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1161\/HYPERTENSIONAHA.123.20900","article-title":"Hypertension statistics for US adults: an open-source web application for analysis and visualization of National Health and Nutrition Examination Survey data","volume":"80","author":"Jaeger","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib50","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/CIR.0000000000001191","article-title":"Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the American Heart Association","volume":"148","author":"Khan","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib51","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib52","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1001\/jamacardio.2020.1731","article-title":"Association of normal systolic blood pressure level with cardiovascular disease in the absence of risk factors","volume":"5","author":"Whelton","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib53","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/S0140-6736(14)60685-1","article-title":"Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people","volume":"383","author":"Rapsomaniki","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib54","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1186\/s12882-020-02151-7","article-title":"The impact of hypertension on chronic kidney disease and end-stage renal disease is greater in men than women: a systematic review and meta-analysis","volume":"21","author":"Weldegiorgis","year":"2020","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.jacc.2025.05.007_bib55","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1053\/j.ajkd.2015.08.027","article-title":"Hypertension and prehypertension and prediction of development of decreased estimated GFR in the general population: a meta-analysis of cohort studies","volume":"67","author":"Garofalo","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacc.2025.05.007_bib56","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1161\/CIRCULATIONAHA.113.004798","article-title":"Early adult to midlife cardiovascular risk factors and cognitive function","volume":"129","author":"Yaffe","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib57","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002275","article-title":"Can antihypertensive treatment restore the risk of cardiovascular disease to ideal levels? The Coronary Artery Risk Development in Young Adults (CARDIA) study and the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"4","author":"Liu","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.05.007_bib58","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002155","article-title":"Residual cardiovascular risk in individuals on blood pressure-lowering treatment","volume":"4","author":"Lieb","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.05.007_bib59","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/CIR.0000000000001191","article-title":"Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the American Heart Association","volume":"148","author":"Khan","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib60","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","article-title":"Development and validation of the American Heart Association's PREVENT equations","volume":"149","author":"Khan","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib61","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jash.2014.07.024","article-title":"A review of blood pressure measurement protocols among hypertension trials: implications for \"evidence-based\" clinical practice","volume":"8","author":"Giorgini","year":"2014","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib62","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/HJH.0000000000001197","article-title":"Sources of inaccuracy in the measurement of adult patients' resting blood pressure in clinical settings: a systematic review","volume":"35","author":"Kallioinen","year":"2017","journal-title":"J Hypertens"},{"issue":"9","key":"10.1016\/j.jacc.2025.05.007_bib63","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6579\/ac890e","article-title":"Sources of automatic office blood pressure measurement error: a systematic review","volume":"43","author":"Liu","year":"2022","journal-title":"Physiol Meas"},{"key":"10.1016\/j.jacc.2025.05.007_bib64","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1161\/HYPERTENSIONAHA.118.11990","article-title":"History and justification of a national blood pressure measurement validated device listing","volume":"73","author":"Cohen","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib65","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1161\/HYP.0000000000000087","article-title":"Measurement of blood pressure in humans: a scientific statement from the American Heart Association","volume":"73","author":"Muntner","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib66","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/jamainternmed.2018.6551","article-title":"Comparing automated office blood pressure readings with other methods of blood pressure measurement for identifying patients with possible hypertension: a systematic review and meta-analysis","volume":"179","author":"Roerecke","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib67","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jamainternmed.2023.3264","article-title":"Effects of cuff size on the accuracy of blood pressure readings: the Cuff(SZ) randomized crossover trial","volume":"183","author":"Ishigami","year":"2023","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib68","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jacc.2018.10.069","article-title":"Blood pressure assessment in adults in clinical practice and clinic-based research: JACC scientific expert panel","volume":"73","author":"Muntner","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib70","doi-asserted-by":"crossref","first-page":"781","DOI":"10.7326\/0003-4819-154-12-201106210-00005","article-title":"Measuring blood pressure for decision making and quality reporting: where and how many measures?","volume":"154","author":"Powers","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib71","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ajh\/hpy053","article-title":"A comparison of the diagnostic accuracy of common office blood pressure measurement protocols","volume":"31","author":"Kronish","year":"2018","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib72","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/jch.14419","article-title":"Using web-based training to improve accuracy of blood pressure measurement among health care professionals: a randomized trial","volume":"24","author":"Hayer","year":"2022","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.jacc.2025.05.007_bib73","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1161\/HYPERTENSIONAHA.120.14719","article-title":"Nonvalidated home blood pressure devices dominate the online marketplace in Australia: major implications for cardiovascular risk management","volume":"75","author":"Picone","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib74","series-title":"Blood pressure procedures manual","year":"2019"},{"key":"10.1016\/j.jacc.2025.05.007_bib75","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1097\/HJH.0000000000002201","article-title":"Blood pressure measurement in atrial fibrillation: review and meta-analysis of evidence on accuracy and clinical relevance","volume":"37","author":"Stergiou","year":"2019","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib76","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/MBP.0000000000000629","article-title":"Conventional office blood pressure measurements and unattended automated office blood pressure compared with home self-measurement and 24-h ambulatory blood pressure monitoring","volume":"28","author":"Fonseca-Reyes","year":"2023","journal-title":"Blood Press Monit"},{"key":"10.1016\/j.jacc.2025.05.007_bib77","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1161\/HYPERTENSIONAHA.117.10026","article-title":"Attended versus unattended blood pressure measurement in a real life setting","volume":"71","author":"Bauer","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib78","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/ajh\/hpac032","article-title":"Automated office blood pressure and the impact of attendance and rest on diagnostic accuracy","volume":"35","author":"Green","year":"2022","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib79","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/jch.13462","article-title":"Unattended versus attended automated office blood pressure: systematic review and meta-analysis of studies using the same methodology for both methods","volume":"21","author":"Kollias","year":"2019","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.jacc.2025.05.007_bib80","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1161\/01.CIR.0000154900.76284.F6","volume":"111","author":"Pickering","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib81","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib82","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"31","author":"Mancia","year":"2013","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib83","doi-asserted-by":"crossref","first-page":"ITC1","DOI":"10.7326\/0003-4819-161-11-201412020-01006","article-title":"In the clinic: hypertension","volume":"161","author":"Weir","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib84","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0140-6736(12)61272-0","article-title":"Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis","volume":"380","author":"Mahmoodi","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib85","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1001\/jamacardio.2021.3187","article-title":"Associations of high-sensitivity troponin and natriuretic peptide levels with outcomes after intensive blood pressure lowering: findings from the SPRINT randomized clinical trial","volume":"6","author":"Berry","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib86","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/jamacardio.2018.4300","article-title":"Association of cardiac injury and malignant left ventricular hypertrophy with risk of heart failure in African Americans: the Jackson Heart Study","volume":"4","author":"Pandey","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib87","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib88","doi-asserted-by":"crossref","first-page":"192","DOI":"10.7326\/M14-1539","article-title":"Diagnostic and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: a systematic review for the US Preventive Services Task Force","volume":"162","author":"Piper","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib89","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/jama.2020.21669","article-title":"Screening for hypertension in adults: updated evidence report and systematic review for the US Preventive Services Task Force","volume":"325","author":"Guirguis-Blake","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib90","series-title":"Self-Measured Blood Pressure Monitoring: Comparative Effectiveness","author":"Uhlig","year":"2012"},{"key":"10.1016\/j.jacc.2025.05.007_bib91","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1001\/jama.2013.6549","article-title":"Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial","volume":"310","author":"Margolis","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib92","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1001\/jama.2014.10057","article-title":"Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR randomized clinical trial","volume":"312","author":"McManus","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002389","article-title":"Self-monitoring of blood pressure in hypertension: a systematic review and individual patient data meta-analysis","volume":"14","author":"Tucker","year":"2017","journal-title":"PLoS Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib94","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jash.2015.12.013","article-title":"Studies comparing ambulatory blood pressure and home blood pressure on cardiovascular disease and mortality outcomes: a systematic review","volume":"10","author":"Shimbo","year":"2016","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/HJH.0000000000003557","article-title":"Ambulatory and home blood pressure monitoring for cardiovascular disease risk evaluation: a systematic review and meta-analysis of prospective cohort studies","volume":"42","author":"Panagiotakos","year":"2024","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib96","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/HYPERTENSIONAHA.110.160911","article-title":"Role of home blood pressure monitoring in overcoming therapeutic inertia and improving hypertension control: a systematic review and meta-analysis","volume":"57","author":"Agarwal","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib97","doi-asserted-by":"crossref","first-page":"691","DOI":"10.7326\/M15-1270","article-title":"Role of ambulatory and home blood pressure monitoring in clinical practice","volume":"163","author":"Shimbo","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib98","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1016\/j.jacc.2020.10.039","article-title":"Reliability of office, home, and ambulatory blood pressure measurements and correlation with left ventricular mass","volume":"76","author":"Schwartz","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib99","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1161\/HYP.0000000000000087","article-title":"Measurement of blood pressure in humans: a scientific statement from the American Heart Association","volume":"73","author":"Muntner","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib100","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1161\/CIRCULATIONAHA.116.027051","article-title":"Thresholds for ambulatory blood pressure among African Americans in the Jackson Heart Study","volume":"135","author":"Ravenell","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib101","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1161\/HYPERTENSIONAHA.118.11657","article-title":"Diagnostic thresholds for blood pressure measured at home in the context of the 2017 hypertension guideline","volume":"72","author":"Vongpatanasin","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib102","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1161\/HYPERTENSIONAHA.118.11946","article-title":"Rationale for ambulatory and home blood pressure monitoring thresholds in the 2017 American College of Cardiology\/American Heart Association guideline","volume":"73","author":"Muntner","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib103","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jash.2015.12.013","article-title":"Studies comparing ambulatory blood pressure and home blood pressure on cardiovascular disease and mortality outcomes: a systematic review","volume":"10","author":"Shimbo","year":"2016","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib104","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1001\/jama.2022.4726","article-title":"Effect of self-monitoring of blood pressure on blood pressure control in pregnant individuals with chronic or gestational hypertension: the BUMP 2 randomized clinical trial","volume":"327","author":"Chappell","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib105","doi-asserted-by":"crossref","first-page":"E42","DOI":"10.1161\/CIR.0000000000000803","article-title":"Self-measured blood pressure monitoring at home: a joint policy statement from the American Heart Association and American Medical Association","volume":"142","author":"Shimbo","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib106","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib107","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/ehjdh\/ztac021","article-title":"Wearable cuffless blood pressure monitoring devices: a systematic review and meta-analysis","volume":"3","author":"Islam","year":"2022","journal-title":"Eur Heart J Digit Health"},{"key":"10.1016\/j.jacc.2025.05.007_bib108","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/s41440-023-01215-z","article-title":"Feasibility and measurement stability of smartwatch-based cuffless blood pressure monitoring: a real-world prospective observational study","volume":"46","author":"Han","year":"2023","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jacc.2025.05.007_bib109","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1097\/HJH.0000000000003224","article-title":"Cuffless blood pressure measuring devices: review and statement by the European Society of Hypertension Working Group on blood pressure monitoring and cardiovascular variability","volume":"40","author":"Stergiou","year":"2022","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib110","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cvdhj.2023.01.001","article-title":"Validating cuffless continuous blood pressure monitoring devices","volume":"4","author":"Hu","year":"2023","journal-title":"Cardiovasc Digit Health J"},{"key":"10.1016\/j.jacc.2025.05.007_bib111","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1097\/HJH.0000000000003483","article-title":"European Society of Hypertension recommendations for the validation of cuffless blood pressure measuring devices: European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability","volume":"41","author":"Stergiou","year":"2023","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib113","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1001\/jama.2018.13467","article-title":"Association of clinical and social factors with excess hypertension risk in Black compared with White US adults","volume":"320","author":"Howard","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib114","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020718","article-title":"Plant-centered diet and risk of incident cardiovascular disease during young to middle adulthood","volume":"10","author":"Choi","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.05.007_bib115","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3945\/an.115.009753","article-title":"Dietary patterns and blood pressure in adults: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Ndanuko","year":"2016","journal-title":"Adv Nutr"},{"key":"10.1016\/j.jacc.2025.05.007_bib116","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/archinte.166.1.79","article-title":"Association between protein intake and blood pressure: the INTERMAP study","volume":"166","author":"Elliott","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib117","doi-asserted-by":"crossref","first-page":"626S","DOI":"10.1093\/ajcn\/65.2.626S","article-title":"The INTERSALT study: background, methods, findings, and implications","volume":"65","author":"Stamler","year":"1997","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jacc.2025.05.007_bib118","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1161\/HYPERTENSIONAHA.117.09928","article-title":"Relation of dietary sodium (salt) to blood pressure and its possible modulation by other dietary factors","volume":"71","author":"Stamler","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib119","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1161\/CIRCULATIONAHA.106.648642","article-title":"Consistently stable or decreased body mass index in young adulthood and longitudinal changes in metabolic syndrome components: the Coronary Artery Risk Development in Young Adults Study","volume":"115","author":"Lloyd-Jones","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib120","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1001\/archinte.162.16.1867","article-title":"Overweight and obesity as determinants of cardiovascular risk: the Framingham experience","volume":"162","author":"Wilson","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib121","article-title":"Secular trends of population-attributable fractions of obesity for hypertension among US population by sex and race\/ethnicity: analysis from NHANES 1999-2018","volume":"41","author":"Zhang","year":"2024","journal-title":"Prev Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib122","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.08.010405","article-title":"Association of obstructive sleep apnea with hypertension: a systematic review and meta-analysis","volume":"8","author":"Hou","year":"2018","journal-title":"J Glob Health"},{"key":"10.1016\/j.jacc.2025.05.007_bib123","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.5664\/jcsm.5024","article-title":"Relationship between duration of sleep and hypertension in adults: a meta-analysis","volume":"11","author":"Wang","year":"2015","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib124","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012139","article-title":"Association between high perceived stress over time and incident hypertension in black adults: findings from the Jackson Heart Study","volume":"8","author":"Spruill","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.05.007_bib125","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.jacc.2014.06.1184","article-title":"Effects of cardiorespiratory fitness on blood pressure trajectory with aging in a cohort of healthy men","volume":"64","author":"Liu","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib126","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/HYPERTENSIONAHA.114.04261","article-title":"Exposure to bisphenol A from drinking canned beverages increases blood pressure","volume":"65","author":"Bae","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib127","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1097\/HJH.0000000000000342","article-title":"Effect of exposure to PM2.5 on blood pressure: a systematic review and meta-analysis","volume":"32","author":"Liang","year":"2014","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib128","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1161\/01.HYP.36.4.477","article-title":"Evidence for a gene influencing blood pressure on chromosome 17","volume":"36","author":"Levy","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib129","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature10405","article-title":"Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk","volume":"478","author":"Ehret","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jacc.2025.05.007_bib130","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s41588-024-01714-w","article-title":"Genome-wide analysis in over 1 million individuals of European ancestry yields improved polygenic risk scores for blood pressure traits","volume":"56","author":"Keaton","year":"2024","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacc.2025.05.007_bib131","doi-asserted-by":"crossref","first-page":"853","DOI":"10.7326\/M19-0223","article-title":"Cardiovascular events and mortality in white coat hypertension: a systematic review and meta-analysis","volume":"170","author":"Cohen","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib132","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/HJH.0000000000000832","article-title":"White-coat hypertension and cardiovascular events: a meta-analysis","volume":"34","author":"Briasoulis","year":"2016","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib133","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1097\/HJH.0000000000000983","article-title":"Is white-coat hypertension associated with increased cardiovascular and mortality risk?","volume":"34","author":"Muntner","year":"2016","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib134","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/HYPERTENSIONAHA.111.180653","article-title":"Significance of white-coat hypertension in older persons with isolated systolic hypertension: a meta-analysis using the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes population","volume":"59","author":"Franklin","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib135","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/ajh.2010.203","article-title":"Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis","volume":"24","author":"Pierdomenico","year":"2011","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib136","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/HJH.0000000000000750","article-title":"White-coat and masked hypertension as risk factors for progression to sustained hypertension: the Finn-Home study","volume":"34","author":"Siven","year":"2016","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib137","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1161\/HYPERTENSIONAHA.109.129882","article-title":"Long-term risk of sustained hypertension in white-coat or masked hypertension","volume":"54","author":"Mancia","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib138","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8817544","article-title":"Long-term risk of progression to sustained hypertension in white-coat hypertension with normal night-time blood pressure values","volume":"2020","author":"Faria","year":"2020","journal-title":"Int J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib139","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.amjhyper.2005.05.014","article-title":"Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension","volume":"18","author":"Pierdomenico","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib140","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1001\/archinte.168.21.2340","article-title":"Prognostic influence of office and ambulatory blood pressures in resistant hypertension","volume":"168","author":"Salles","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib141","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1161\/HYP.0000000000000084","article-title":"Resistant hypertension: detection, evaluation, and management: a scientific statement from the American Heart Association","volume":"72","author":"Carey","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib142","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1161\/HYPERTENSIONAHA.121.18064","article-title":"Prognostic impact of home blood pressures for adverse cardiovascular outcomes and mortality in patients with resistant hypertension: a prospective cohort study","volume":"78","author":"Cardoso","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib143","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/HYPERTENSIONAHA.113.02741","article-title":"Prognosis of white-coat and masked hypertension: International Database of HOme blood pressure in relation to Cardiovascular Outcome","volume":"63","author":"Stergiou","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib144","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1097\/HJH.0000000000002109","article-title":"A comparative meta-analysis of prospective observational studies on masked hypertension and masked uncontrolled hypertension defined by ambulatory and home blood pressure","volume":"37","author":"Zhang","year":"2019","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib145","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.hlc.2019.08.006","article-title":"Masked hypertension: a systematic review","volume":"29","author":"Thakkar","year":"2020","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.jacc.2025.05.007_bib146","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1161\/HYP.0000000000000087","article-title":"Measurement of blood pressure in humans: a scientific statement from the American Heart Association","volume":"73","author":"Muntner","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib147","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jacc.2018.10.069","article-title":"Blood pressure assessment in adults in clinical practice and clinic-based research: JACC scientific expert panel","volume":"73","author":"Muntner","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib148","doi-asserted-by":"crossref","first-page":"192","DOI":"10.7326\/M14-1539","article-title":"Diagnostic and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: a systematic review for the US Preventive Services Task Force","volume":"162","author":"Piper","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib149","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/jama.2020.21669","article-title":"Screening for hypertension in adults: updated evidence report and systematic review for the US Preventive Services Task Force","volume":"325","author":"Guirguis-Blake","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib150","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jash.2015.12.013","article-title":"Studies comparing ambulatory blood pressure and home blood pressure on cardiovascular disease and mortality outcomes: a systematic review","volume":"10","author":"Shimbo","year":"2016","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/HJH.0000000000003557","article-title":"Ambulatory and home blood pressure monitoring for cardiovascular disease risk evaluation: a systematic review and meta-analysis of prospective cohort studies","volume":"42","author":"Panagiotakos","year":"2024","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib152","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jash.2014.07.024","article-title":"A review of blood pressure measurement protocols among hypertension trials: implications for \"evidence-based\" clinical practice","volume":"8","author":"Giorgini","year":"2014","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib153","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.jacc.2016.08.035","article-title":"The cardiovascular risk of white-coat hypertension","volume":"68","author":"Franklin","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib154","doi-asserted-by":"crossref","first-page":"890","DOI":"10.7326\/M19-1134","article-title":"Should out-of-office monitoring be performed for detecting white coat hypertension?","volume":"170","author":"Shimbo","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib155","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1097\/HJH.0b013e32832db8b9","article-title":"Preventing misdiagnosis of ambulatory hypertension: algorithm using office and home blood pressures","volume":"27","author":"Shimbo","year":"2009","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib156","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/0895-7061(95)00151-E","article-title":"White coat hypertension and white coat effect. Similarities and differences","volume":"8","author":"Verdecchia","year":"1995","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib157","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/archinte.165.13.1541","article-title":"White-coat hypertension as a risk factor for the development of home hypertension: the Ohasama study","volume":"165","author":"Ugajin","year":"2005","journal-title":"Arch Intern Med"},{"issue":"7","key":"10.1016\/j.jacc.2025.05.007_bib158","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.116.003421","article-title":"Predicted atherosclerotic cardiovascular disease risk and masked hypertension among Blacks in the Jackson Heart Study","volume":"10","author":"Anstey","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2025.05.007_bib159","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/ajh.2012.15","article-title":"Masked hypertension and prehypertension: diagnostic overlap and interrelationships with left ventricular mass: the Masked Hypertension Study","volume":"25","author":"Shimbo","year":"2012","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib160","article-title":"Prospective external validation of the Predicting Out-of-OFfice Blood Pressure (PROOF-BP) strategy for triaging ambulatory monitoring in the diagnosis and management of hypertension: observational cohort study","volume":"361","author":"Sheppard","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2025.05.007_bib161","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/ajh\/hpac005","article-title":"Predicting out-of-office blood pressure in a diverse US population","volume":"35","author":"Bellows","year":"2022","journal-title":"Am J Hypertens"},{"issue":"5","key":"10.1016\/j.jacc.2025.05.007_bib162","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/ajh\/hpaf017","article-title":"The diagnostic accuracy of using borderline high office blood pressure thresholds to diagnose masked hypertension according to the 2017 American College of Cardiology\/American Heart Association blood pressure guideline","volume":"38","author":"Walsh","year":"2025","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib163","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1161\/HYPERTENSIONAHA.117.09061","article-title":"Hypertension in Blacks: unanswered questions and future directions for the JHS (Jackson Heart Study)","volume":"69","author":"Muntner","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib164","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102736","article-title":"Efficacy of antihypertensive treatment for target organ protection in patients with masked hypertension (ANTI-MASK): a multicentre, double-blind, placebo-controlled trial","volume":"74","author":"Huang","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jacc.2025.05.007_bib165","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1016\/j.jacc.2018.04.017","article-title":"Effect of lowering home blood pressure on subclinical cardiovascular disease in masked uncontrolled hypertension","volume":"71","author":"Hoshide","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib166","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/ajh\/hpv058","article-title":"Is isolated nocturnal hypertension a reproducible phenotype?","volume":"29","author":"Abdalla","year":"2016","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib167","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/HYPERTENSIONAHA.107.087767","article-title":"Is isolated nocturnal hypertension a novel clinical entity? Findings from a Chinese population study","volume":"50","author":"Li","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib168","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/HYPERTENSIONAHA.122.19372","article-title":"Toward precision medicine: circadian rhythm of blood pressure and chronotherapy for hypertension - 2021 NHLBI workshop report","volume":"80","author":"Gumz","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib169","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1097\/HJH.0000000000003240","article-title":"Bedtime dosing of antihypertensive medications: systematic review and consensus statement: International Society of Hypertension position paper endorsed by World Hypertension League and European Society of Hypertension","volume":"40","author":"Stergiou","year":"2022","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib170","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib171","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib172","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.jacc.2020.02.052","article-title":"Primary aldosteronism in patients in China with recently detected hypertension","volume":"75","author":"Xu","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib173","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The unrecognized prevalence of primary aldosteronism: a cross-sectional study","volume":"173","author":"Brown","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib174","doi-asserted-by":"crossref","first-page":"630","DOI":"10.7326\/M17-0882","article-title":"The spectrum of subclinical primary aldosteronism and incident hypertension: a cohort study","volume":"167","author":"Brown","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib175","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s11739-019-02273-3","article-title":"How common is obstructive sleep apnea in young hypertensive patients?","volume":"15","author":"Jinchai","year":"2020","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib176","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1161\/HYPERTENSIONAHA.111.179788","article-title":"Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension","volume":"58","author":"Pedrosa","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib177","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1001\/jama.283.14.1829","article-title":"Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study","volume":"283","author":"Nieto","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib178","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/CIRCULATIONAHA.123.066389","article-title":"Subclinical primary aldosteronism and cardiovascular health: a population-based cohort study","volume":"149","author":"Hundemer","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib179","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib180","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1161\/HYP.0000000000000217","article-title":"Revascularization for renovascular disease: a scientific statement from the American Heart Association","volume":"79","author":"Bhalla","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib181","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1001\/jamainternmed.2021.6819","article-title":"Prevalence of medications that may raise blood pressure among adults with hypertension in the United States","volume":"182","author":"Vitarello","year":"2022","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib182","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/CIRCULATIONAHA.121.056015","article-title":"Regular acetaminophen use and blood pressure in people with hypertension: the PATH-BP trial","volume":"145","author":"MacIntyre","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib183","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e11278","article-title":"Assessment of potential drug-drug interactions among outpatients in a tertiary care hospital: focusing on the role of P-glycoprotein and CYP3A4 (retrospective observational study)","volume":"8","author":"Patel","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.jacc.2025.05.007_bib184","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib185","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.1009","article-title":"Use and performance of the STOP-Bang questionnaire for obstructive sleep apnea screening across geographic regions: a systematic review and meta-analysis","volume":"4","author":"Pivetta","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2025.05.007_bib186","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s11325-021-02450-9","article-title":"Diagnostic accuracy of screening questionnaires for obstructive sleep apnoea in adults in different clinical cohorts: a systematic review and meta-analysis","volume":"26","author":"Bernhardt","year":"2022","journal-title":"Sleep Breath"},{"key":"10.1016\/j.jacc.2025.05.007_bib187","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1053\/j.ajkd.2021.08.003","article-title":"A unifying approach for GFR estimation: recommendations of the NKF-ASN Task Force on reassessing the inclusion of race in diagnosing kidney disease","volume":"79","author":"Delgado","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacc.2025.05.007_bib188","doi-asserted-by":"crossref","first-page":"269","DOI":"10.7326\/M23-1138","article-title":"Association of low glomerular filtration rate with adverse outcomes at older age in a large population with routinely measured cystatin C","volume":"177","author":"Fu","year":"2024","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib189","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2025.05.007_bib190","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1210\/er.2017-00054","article-title":"Screening for endocrine hypertension: an Endocrine Society scientific statement","volume":"38","author":"Young","year":"2017","journal-title":"Endocrine Rev"},{"key":"10.1016\/j.jacc.2025.05.007_bib191","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1530\/EJE-20-0628","article-title":"Epidemiology of pheochromocytoma and paraganglioma: population-based cohort study","volume":"184","author":"Leung","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jacc.2025.05.007_bib192","doi-asserted-by":"crossref","first-page":"e2251","DOI":"10.1210\/clinem\/dgaa965","article-title":"Incidence and clinical presentation of pheochromocytoma and sympathetic paraganglioma: a population-based study","volume":"106","author":"Ebbehoj","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2025.05.007_bib193","doi-asserted-by":"crossref","first-page":"e223","DOI":"10.1016\/j.jacc.2022.08.004","article-title":"2022 ACC\/AHA guideline for the diagnosis and management of aortic disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"80","author":"Isselbacher","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib194","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1097\/HJH.0000000000003252","article-title":"Diagnosis and management of hypertension in patients with Cushing's syndrome: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension","volume":"40","author":"Fallo","year":"2022","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11102-020-01091-7","article-title":"A Pituitary Society update to acromegaly management guidelines","volume":"24","author":"Fleseriu","year":"2021","journal-title":"Pituitary"},{"key":"10.1016\/j.jacc.2025.05.007_bib196","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.jacc.2019.03.010","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"74","author":"Arnett","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib197","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1016\/S2468-2667(17)30003-8","article-title":"The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis","volume":"2","author":"Roerecke","year":"2017","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.jacc.2025.05.007_bib198","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026477","article-title":"Coffee and green tea consumption and cardiovascular disease mortality among people with and without hypertension","volume":"12","author":"Teramoto","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.05.007_bib199","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/jhh.2017.45","article-title":"The association between consistent licorice ingestion, hypertension and hypokalaemia: a systematic review and meta-analysis","volume":"31","author":"Penninkilampi","year":"2017","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib200","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1751-7176.2011.00509.x","article-title":"Central sympatholytic drugs","volume":"13","author":"Vongpatanasin","year":"2011","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.jacc.2025.05.007_bib201","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1161\/HYPERTENSIONAHA.119.13341","article-title":"Paroxysmal hypertension associated with presyncope","volume":"74","author":"Luther","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib202","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-2528","article-title":"Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit\/hyperactivity disorder in children and adolescents","volume":"144","author":"Wolraich","year":"2019","journal-title":"Pediatrics"},{"key":"10.1016\/j.jacc.2025.05.007_bib203","first-page":"18m02299","article-title":"Acute blood pressure changes associated with antipsychotic administration to psychiatric inpatients","volume":"20","author":"Parks","year":"2018","journal-title":"Prim Care Companion CNS Disord"},{"key":"10.1016\/j.jacc.2025.05.007_bib204","doi-asserted-by":"crossref","first-page":"736","DOI":"10.5498\/wjp.v11.i10.736","article-title":"Antipsychotics cardiotoxicity: what's known and what's next","volume":"11","author":"Li","year":"2021","journal-title":"World J Psychiatry"},{"key":"10.1016\/j.jacc.2025.05.007_bib205","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1161\/HYPERTENSIONAHA.122.20018","article-title":"Oral contraceptive pills and hypertension: a review of current evidence and recommendations","volume":"80","author":"Cameron","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib206","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1200\/JCO.23.01157","article-title":"PRESTO: a phase III, open-label study of intensification of androgen blockade in patients with high-risk biochemically relapsed castration-sensitive prostate cancer (AFT-19)","volume":"42","author":"Aggarwal","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jacc.2025.05.007_bib207","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0889-8529(02)00013-0","article-title":"Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature","volume":"31","author":"Montori","year":"2002","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.jacc.2025.05.007_bib208","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005574","article-title":"Quantitative value of aldosterone-renin ratio for detection of aldosterone-producing adenoma: the Aldosterone-Renin Ratio for Primary Aldosteronism (AQUARR) study","volume":"6","author":"Maiolino","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.05.007_bib209","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The unrecognized prevalence of primary aldosteronism: a cross-sectional study","volume":"173","author":"Brown","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib210","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2025.05.007_bib211","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41574-022-00730-2","article-title":"Primary aldosteronism: a multidimensional syndrome","volume":"18","author":"Turcu","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jacc.2025.05.007_bib212","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacc.2025.05.007_bib213","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/HJH.0000000000002216","article-title":"Renal damage in primary aldosteronism: a systematic review and meta-analysis","volume":"38","author":"Monticone","year":"2020","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib214","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents","volume":"89","author":"Mulatero","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2025.05.007_bib215","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib216","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib217","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1055\/s-0031-1295438","article-title":"Prevalence of primary aldosteronism in patient's cohorts and in population-based studies-a review of the current literature","volume":"44","author":"Hannemann","year":"2012","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.jacc.2025.05.007_bib218","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/HYPERTENSIONAHA.118.11568","article-title":"Renal outcomes in medically and surgically treated primary aldosteronism","volume":"72","author":"Hundemer","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib219","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study","volume":"6","author":"Hundemer","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacc.2025.05.007_bib220","doi-asserted-by":"crossref","first-page":"289","DOI":"10.7326\/M20-4873","article-title":"Testing for primary aldosteronism and mineralocorticoid receptor antagonist use among U.S. veterans: a retrospective cohort study","volume":"174","author":"Cohen","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib221","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1161\/HYPERTENSIONAHA.121.18118","article-title":"Screening rates for primary aldosteronism among individuals with hypertension plus hypokalemia: a population-based retrospective cohort study","volume":"79","author":"Hundemer","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib222","doi-asserted-by":"crossref","first-page":"3","DOI":"10.7812\/TPP\/23.096","article-title":"Hyperaldosteronism screening and findings from a large diverse population with resistant hypertension within an integrated health system","volume":"28","author":"Kim","year":"2024","journal-title":"Perm J"},{"key":"10.1016\/j.jacc.2025.05.007_bib223","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.036373","article-title":"Trends in primary aldosteronism screening among high-risk hypertensive adults","volume":"13","author":"Kositanurit","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.05.007_bib224","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1097\/HJH.0000000000003513","article-title":"Cost-effectiveness of screening for primary aldosteronism in hypertensive patients in Australia: a Markov modelling analysis","volume":"41","author":"Woode","year":"2023","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib225","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1055\/s-0035-1559645","article-title":"Cost-effectiveness analysis of the diagnosis and treatment of primary aldosteronism in Japan","volume":"47","author":"Sato","year":"2015","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.jacc.2025.05.007_bib226","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0889-8529(02)00013-0","article-title":"Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature","volume":"31","author":"Montori","year":"2002","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.jacc.2025.05.007_bib227","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/01.HYP.0000038478.59760.41","article-title":"Drug effects on aldosterone\/plasma renin activity ratio in primary aldosteronism","volume":"40","author":"Mulatero","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib228","doi-asserted-by":"crossref","first-page":"e1280","DOI":"10.1210\/clinem\/dgad654","article-title":"Time to benefit of surgery vs targeted medical therapy for patients with primary aldosteronism: a meta-analysis","volume":"109","author":"Samnani","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2025.05.007_bib229","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s12022-014-9307-x","article-title":"Aldosterone-secreting adrenal cortical carcinoma. A case report and review of the literature","volume":"25","author":"Griffin","year":"2014","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.jacc.2025.05.007_bib230","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.amjcard.2014.06.033","article-title":"Meta-analysis of revascularization versus medical therapy for atherosclerotic renal artery stenosis","volume":"114","author":"Riaz","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib231","first-page":"CD002944","article-title":"Balloon angioplasty, with and without stenting, versus medical therapy for hypertensive patients with renal artery stenosis","volume":"2014","author":"Jenks","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2025.05.007_bib232","doi-asserted-by":"crossref","first-page":"635","DOI":"10.7326\/M16-1053","article-title":"Comparative effectiveness of management strategies for renal artery stenosis: an updated systematic review","volume":"165","author":"Raman","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib233","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/HYPERTENSIONAHA.110.152918","article-title":"Efficacy of revascularization for renal artery stenosis caused by fibromuscular dysplasia: a systematic review and meta-analysis","volume":"56","author":"Trinquart","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib234","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1161\/CIRCULATIONAHA.112.091223","article-title":"The United States registry for fibromuscular dysplasia: results in the first 447 patients","volume":"125","author":"Olin","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib235","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1161\/HYP.0000000000000217","article-title":"Revascularization for renovascular disease: a scientific statement from the American Heart Association","volume":"79","author":"Bhalla","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib236","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1161\/HYPERTENSIONAHA.116.07744","article-title":"Relationship of albuminuria and renal artery stent outcomes: results from the CORAL randomized clinical trial (Cardiovascular Outcomes with Renal Artery Lesions)","volume":"68","author":"Murphy","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib237","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.jvir.2016.05.001","article-title":"Mortality and renal replacement therapy after renal artery stent placement for atherosclerotic renovascular disease","volume":"27","author":"Misra","year":"2016","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib238","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1310753","article-title":"Stenting and medical therapy for atherosclerotic renal-artery stenosis","volume":"370","author":"Cooper","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib239","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/cts.13241","article-title":"Weight reduction added to CPAP decreases blood pressure and triglyceride level in OSA: systematic review and meta-analysis","volume":"15","author":"Kov\u00e1cs","year":"2022","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.jacc.2025.05.007_bib240","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2021.101446","article-title":"Efficacy of continuous positive airway pressure (CPAP) in patients with obstructive sleep apnea (OSA) and resistant hypertension (RH): systematic review and meta-analysis","volume":"58","author":"Labarca","year":"2021","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.jacc.2025.05.007_bib241","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1590\/s1806-37562016000000190","article-title":"Effects of continuous positive airway pressure on blood pressure in patients with resistant hypertension and obstructive sleep apnea: a systematic review and meta-analysis of six randomized controlled trials","volume":"43","author":"Lei","year":"2017","journal-title":"J Bras Pneumol"},{"key":"10.1016\/j.jacc.2025.05.007_bib242","doi-asserted-by":"crossref","first-page":"479","DOI":"10.5664\/jcsm.6506","article-title":"Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of Sleep Medicine clinical practice guideline","volume":"13","author":"Kapur","year":"2017","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib243","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.08.010405","article-title":"Association of obstructive sleep apnea with hypertension: a systematic review and meta-analysis","volume":"8","author":"Hou","year":"2018","journal-title":"J Glob Health"},{"key":"10.1016\/j.jacc.2025.05.007_bib244","doi-asserted-by":"crossref","first-page":"355","DOI":"10.5664\/jcsm.3600","article-title":"Sleep apnea and 20-year follow-up for all-cause mortality, stroke, and cancer incidence and mortality in the Busselton Health Study cohort","volume":"10","author":"Marshall","year":"2014","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib245","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/HJH.0000000000003131","article-title":"Effect of different treatments for obstructive sleep apnoea on blood pressure","volume":"40","author":"Kou","year":"2022","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib246","doi-asserted-by":"crossref","first-page":"335","DOI":"10.5664\/jcsm.7640","article-title":"Treatment of adult obstructive sleep apnea with positive airway pressure: an American Academy of Sleep Medicine clinical practice guideline","volume":"15","author":"Patil","year":"2019","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib247","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMoa1606599","article-title":"CPAP for prevention of cardiovascular events in obstructive sleep apnea","volume":"375","author":"McEvoy","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib248","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2022.101590","article-title":"Effect of sleep surgery on blood pressure in adults with obstructive sleep apnea: a systematic review and meta-analysis","volume":"62","author":"Kang","year":"2022","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.jacc.2025.05.007_bib249","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jamaoto.2023.0161","article-title":"Targeted hypoglossal nerve stimulation for patients with obstructive sleep apnea: a randomized clinical trial","volume":"149","author":"Schwartz","year":"2023","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jacc.2025.05.007_bib250","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.3390\/jcm10071485","article-title":"Body mass index reduction and selected cardiometabolic risk factors in obstructive sleep apnea: meta-analysis","volume":"10","author":"Stelmach-Mardas","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib251","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa2404881","article-title":"Tirzepatide for the treatment of obstructive sleep apnea and obesity","volume":"391","author":"Malhotra","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib252","article-title":"Association between obstructive sleep apnea and resistant hypertension: systematic review and meta-analysis","volume":"10","author":"Ahmed","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jacc.2025.05.007_bib253","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11906-022-01181-w","article-title":"Obstructive sleep apnea and hypertension: updates to a critical relationship","volume":"24","author":"Brown","year":"2022","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.jacc.2025.05.007_bib254","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/HJH.0000000000002664","article-title":"The HIPARCO-2 study: long-term effect of continuous positive airway pressure on blood pressure in patients with resistant hypertension: a multicenter prospective study","volume":"39","author":"Navarro-Soriano","year":"2021","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib255","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1161\/CIR.0000000000001078","article-title":"Life's essential 8: updating and enhancing the American Heart Association's construct of cardiovascular health: a Presidential Advisory from the American Heart Association","volume":"146","author":"Lloyd-Jones","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib256","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1161\/HYPERTENSIONAHA.123.21224","article-title":"Alcohol intake and blood pressure levels: a dose-response meta-analysis of nonexperimental cohort studies","volume":"80","author":"Di Federico","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib257","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/archinte.1997.00440270105009","article-title":"Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II","volume":"157","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib258","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1161\/01.HYP.0000094221.86888.AE","article-title":"Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials","volume":"42","author":"Neter","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib259","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1001\/jama.1992.03480090061028","article-title":"The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the trials of Hypertension Prevention, phase I","volume":"267","author":"Whelton","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib260","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1001\/jama.279.11.839","article-title":"Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE)","volume":"279","author":"Whelton","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib261","doi-asserted-by":"crossref","first-page":"652s","DOI":"10.1093\/ajcn\/65.2.652S","article-title":"Efficacy of nonpharmacologic interventions in adults with high-normal blood pressure: results from phase 1 of the Trials of Hypertension Prevention","volume":"65","author":"Whelton","year":"1997","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jacc.2025.05.007_bib262","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/jch.14661","article-title":"Effect of weight loss on blood pressure changes in overweight patients: a systematic review and meta-analysis","volume":"25","author":"Yang","year":"2023","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.jacc.2025.05.007_bib263","article-title":"Long-term effects of weight-reducing diets in people with hypertension","volume":"2","author":"Semlitsch","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2025.05.007_bib264","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/obr.12433","article-title":"Interventions that cause weight loss and the impact on cardiovascular risk factors: a systematic review and meta-analysis","volume":"17","author":"Zomer","year":"2016","journal-title":"Obes Rev"},{"key":"10.1016\/j.jacc.2025.05.007_bib265","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1001\/archinternmed.2009.470","article-title":"Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study","volume":"170","author":"Blumenthal","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib266","first-page":"2083","article-title":"Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial","volume":"289","author":"Appel","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib267","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJM199704173361601","article-title":"A clinical trial of the effects of dietary patterns on blood pressure","volume":"336","author":"Appel","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib268","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1056\/NEJM200101043440101","article-title":"DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet","volume":"344","author":"Sacks","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib269","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1093\/advances\/nmaa041","article-title":"Dietary Approaches to Stop Hypertension (DASH) diet and blood pressure reduction in adults with and without hypertension: a systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Filippou","year":"2020","journal-title":"Adv Nutr"},{"key":"10.1016\/j.jacc.2025.05.007_bib270","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.016804","article-title":"Nonpharmacologic interventions for reducing blood pressure in adults with prehypertension to established hypertension","volume":"9","author":"Fu","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.05.007_bib271","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1080\/10408398.2018.1463967","article-title":"Comparative effects of different dietary approaches on blood pressure in hypertensive and pre-hypertensive patients: a systematic review and network meta-analysis","volume":"59","author":"Schwingshackl","year":"2019","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1016\/j.jacc.2025.05.007_bib272","article-title":"Effect of lower sodium intake on health: systematic review and meta-analyses","volume":"346","author":"Aburto","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2025.05.007_bib273","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1161\/CIRCULATIONAHA.120.050371","article-title":"Blood pressure effects of sodium reduction: dose-response meta-analysis of experimental studies","volume":"143","author":"Filippini","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib274","first-page":"Cd004022","article-title":"Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride","volume":"12","author":"Graudal","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2025.05.007_bib275","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0140-6736(11)61174-4","article-title":"Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials","volume":"378","author":"He","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib276","doi-asserted-by":"crossref","first-page":"643","DOI":"10.7326\/M23-2626","article-title":"Long-term effect of salt substitution for cardiovascular outcomes: a systematic review and meta-analysis","volume":"177","author":"Greenwood","year":"2024","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib277","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1056\/NEJMoa2105675","article-title":"Effect of salt substitution on cardiovascular events and death","volume":"385","author":"Neal","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib278","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0277929","article-title":"Effect of salt reduction interventions in lowering blood pressure: a comprehensive systematic review and meta-analysis of controlled clinical trials","volume":"17","author":"Aliasgharzadeh","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2025.05.007_bib279","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1136\/heartjnl-2018-314036","article-title":"Effect of low-sodium salt substitutes on blood pressure, detected hypertension, stroke and mortality","volume":"105","author":"Hernandez","year":"2019","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2025.05.007_bib280","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12872-020-01347-x","article-title":"The hypotensive effect of salt substitutes in stage 2 hypertension: a systematic review and meta-analysis","volume":"20","author":"Jafarnejad","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jacc.2025.05.007_bib281","article-title":"Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses","volume":"346","author":"Aburto","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2025.05.007_bib282","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015719","article-title":"Potassium intake and blood pressure: a dose-response meta-analysis of randomized controlled trials","volume":"9","author":"Filippini","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.05.007_bib283","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijcard.2016.12.048","article-title":"The effect of potassium supplementation on blood pressure in hypertensive subjects: a systematic review and meta-analysis","volume":"230","author":"Filippini","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib284","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/01.hjh.0000199800.72563.26","article-title":"Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials","volume":"24","author":"Dickinson","year":"2006","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib285","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1016\/S2468-2667(17)30003-8","article-title":"The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis","volume":"2","author":"Roerecke","year":"2017","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.jacc.2025.05.007_bib286","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1111\/j.1360-0443.2008.02317.x","article-title":"Blood pressure reduction during treatment for alcohol dependence: results from the Combining Medications and Behavioral Interventions for Alcoholism (COMBINE) study","volume":"103","author":"Stewart","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.jacc.2025.05.007_bib287","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1161\/hy1101.093424","article-title":"Effects of alcohol reduction on blood pressure","volume":"38","author":"Xin","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib288","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.mayocp.2013.10.030","article-title":"Isometric exercise training for blood pressure management: a systematic review and meta-analysis","volume":"89","author":"Carlson","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2025.05.007_bib289","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.004473","article-title":"Exercise training for blood pressure: a systematic review and meta-analysis","volume":"2","author":"Cornelissen","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.05.007_bib290","first-page":"622","article-title":"The evolution of a Canadian hypertension education program recommendation: the impact of resistance training on resting blood pressure in adults as an example","volume":"29","author":"Rossi","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib291","doi-asserted-by":"crossref","first-page":"493","DOI":"10.7326\/0003-4819-136-7-200204020-00006","article-title":"Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials","volume":"136","author":"Whelton","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib292","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1136\/bjsports-2022-106503","article-title":"Exercise training and resting blood pressure: a large-scale pairwise and network meta-analysis of randomised controlled trials","volume":"57","author":"Edwards","year":"2023","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib293","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41440-023-01467-9","article-title":"Effects of aerobic exercise on blood pressure in patients with hypertension: a systematic review and dose-response meta-analysis of randomized trials","volume":"47","author":"Jabbarzadeh","year":"2024","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jacc.2025.05.007_bib294","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1097\/HJH.0000000000003455","article-title":"Exercise characteristics and blood pressure reduction after combined aerobic and resistance training: a systematic review with meta-analysis and meta-regression","volume":"41","author":"Schneider","year":"2023","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib295","article-title":"Effect of leisure-time physical activity on blood pressure in people with hypertension: a systematic review and meta-analysis","volume":"13","author":"Shariful","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacc.2025.05.007_bib296","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ctim.2017.07.008","article-title":"Transcendental meditation for lowering blood pressure: an overview of systematic reviews and meta-analyses","volume":"34","author":"Ooi","year":"2017","journal-title":"Complement Ther Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib297","first-page":"Cd010072","article-title":"Yoga for the primary prevention of cardiovascular disease","volume":"2014","author":"Hartley","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2025.05.007_bib298","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.mayocp.2018.09.023","article-title":"Yoga as antihypertensive lifestyle therapy: a systematic review and meta-analysis","volume":"94","author":"Wu","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2025.05.007_bib299","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/jamacardio.2019.0529","article-title":"Lifetime risks for hypertension by contemporary guidelines in African American and White men and women","volume":"4","author":"Chen","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib300","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/jama.287.8.1003","article-title":"Residual lifetime risk for developing hypertension in middle-aged women and men: the Framingham Heart Study","volume":"287","author":"Vasan","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib301","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1161\/CIR.0000000000001078","article-title":"Life's essential 8: updating and enhancing the American Heart Association's construct of cardiovascular health: a Presidential Advisory from the American Heart Association","volume":"146","author":"Lloyd-Jones","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib302","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1161\/CIRCULATIONAHA.106.648642","article-title":"Consistently stable or decreased body mass index in young adulthood and longitudinal changes in metabolic syndrome components","volume":"115","author":"Lloyd-Jones","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib303","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/ajh\/hpae047","article-title":"Association of cardiovascular health in young adulthood with long-term blood pressure trajectories","volume":"37","author":"Guo","year":"2024","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib304","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/CIRCULATIONAHA.113.006032","article-title":"Lower levels of sodium intake and reduced cardiovascular risk","volume":"129","author":"Cook","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib305","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/bmj.39147.604896.55","article-title":"Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP)","volume":"334","author":"Cook","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2025.05.007_bib306","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","year":"2004","journal-title":"Lancet"},{"issue":"Suppl 3","key":"10.1016\/j.jacc.2025.05.007_bib307","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP161365.GL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity","volume":"22","author":"Garvey","year":"2016","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jacc.2025.05.007_bib308","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1016\/j.jacc.2013.11.004","article-title":"2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and The Obesity Society","volume":"63","author":"Jensen","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib309","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1161\/CIRCULATIONAHA.117.032130","article-title":"Effects of bariatric surgery in obese patients with hypertension the GATEWAY randomized trial (gastric bypass to treat obese patients with steady hypertension)","volume":"137","author":"Schiavon","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib310","article-title":"Long-term effects of weight-reducing drugs in people with hypertension","volume":"1","author":"Siebenhofer","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2025.05.007_bib311","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib312","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1053\/j.gastro.2017.12.024","article-title":"Effects of weight-loss medications on cardiometabolic risk profiles: a systematic review and network meta-analysis","volume":"154","author":"Khera","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacc.2025.05.007_bib313","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1001\/jama.2018.7777","article-title":"Behavioral and pharmacotherapy weight loss interventions to prevent obesity-related morbidity and mortality in adults: updated evidence report and systematic review for the US Preventive Services Task Force","volume":"320","author":"LeBlanc","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib314","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13435","article-title":"Effect of glucagon-like peptide-1 receptor agonists on body weight in adults with obesity without diabetes mellitus-a systematic review and meta-analysis of randomized control trials","volume":"23","author":"Iqbal","year":"2022","journal-title":"Obes Rev"},{"key":"10.1016\/j.jacc.2025.05.007_bib315","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib316","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1161\/HYPERTENSIONAHA.123.22022","article-title":"Tirzepatide reduces 24-hour ambulatory blood pressure in adults with body mass index \u226527 kg\/m(2): SURMOUNT-1 ambulatory blood pressure monitoring substudy","volume":"81","author":"de Lemos","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib317","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1161\/HYPERTENSIONAHA.123.22575","article-title":"Recommendations for the use of dietary fiber to improve blood pressure control","volume":"81","author":"Jama","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib318","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108108","article-title":"Effect of different dietary approaches compared with a regular diet on systolic and diastolic blood pressure in patients with type 2 diabetes: A systematic review and meta-analysis","volume":"163","author":"Abbasnezhad","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jacc.2025.05.007_bib319","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0007114514003341","article-title":"Effects of the Dietary Approach to Stop Hypertension (DASH) diet on cardiovascular risk factors: a systematic review and meta-analysis","volume":"113","author":"Siervo","year":"2015","journal-title":"Br J Nutr"},{"key":"10.1016\/j.jacc.2025.05.007_bib320","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1161\/HYPERTENSIONAHA.115.06853","article-title":"Effects of different dietary interventions on blood pressure: systematic review and meta-analysis of randomized controlled trials","volume":"67","author":"Gay","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib321","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1001\/jama.2018.13467","article-title":"Association of clinical and social factors with excess hypertension risk in Black compared with White US adults","volume":"320","author":"Howard","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib322","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1001\/archinte.159.3.285","article-title":"Effects of dietary patterns on blood pressure: subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial","volume":"159","author":"Svetkey","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib326","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.clnu.2016.12.019","article-title":"Efficacy of nutritional recommendations given by registered dietitians compared to other healthcare providers in reducing arterial blood pressure: systematic review and meta-analysis","volume":"37","author":"Riegel","year":"2018","journal-title":"Clin Nut"},{"key":"10.1016\/j.jacc.2025.05.007_bib327","doi-asserted-by":"crossref","first-page":"309","DOI":"10.7326\/M14-0180","article-title":"Effects of low-carbohydrate and low-fat diets: a randomized trial","volume":"161","author":"Bazzano","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib328","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1161\/CIRCULATIONAHA.110.009159","article-title":"Effect of dietary protein supplementation on blood pressure: a randomized, controlled trial","volume":"124","author":"He","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib329","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.amjmed.2011.04.024","article-title":"Meta-analysis comparing Mediterranean to low-fat diets for modification of cardiovascular risk factors","volume":"124","author":"Nordmann","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib330","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/jamainternmed.2013.14547","article-title":"Vegetarian diets and blood pressure: a meta-analysis","volume":"174","author":"Yokoyama","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib331","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1002\/fsn3.3212","article-title":"The effect of a low versus high sodium diet on blood pressure in diabetic patients: a systematic review and meta-analysis of clinical trials","volume":"11","author":"Gholizadeh-Moghaddam","year":"2023","journal-title":"Food Sci Nutr"},{"key":"10.1016\/j.jacc.2025.05.007_bib332","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1001\/jama.2023.23651","article-title":"Effect of dietary sodium on blood pressure: a crossover trial","volume":"330","author":"Gupta","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib333","article-title":"Effect of dose and duration of reduction in dietary sodium on blood pressure levels: systematic review and meta-analysis of randomised trials","volume":"368","author":"Huang","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2025.05.007_bib334","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/nutrit\/nuab110","article-title":"Reducing salt intake: a systematic review and meta-analysis of behavior change interventions in adults","volume":"80","author":"Khalesi","year":"2022","journal-title":"Nutr Rev"},{"key":"10.1016\/j.jacc.2025.05.007_bib335","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1038\/s41440-022-00990-5","article-title":"Impact of different dietary sodium reduction strategies on blood pressure: a systematic review","volume":"45","author":"Lai","year":"2022","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jacc.2025.05.007_bib336","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.numecd.2021.02.019","article-title":"Effect of dietary sodium restriction on blood pressure in type 2 diabetes: a meta-analysis of randomized controlled trials","volume":"31","author":"Ren","year":"2021","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.jacc.2025.05.007_bib337","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s13668-023-00477-w","article-title":"Effective and scalable interventions to reduce sodium intake: a systematic review and meta-analysis","volume":"12","author":"Vargas-Meza","year":"2023","journal-title":"Curr Nutr Rep"},{"key":"10.1016\/j.jacc.2025.05.007_bib338","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5334\/gh.1281","article-title":"Effects of behavioral interventions for salt reduction on blood pressure and urinary sodium excretion: a systematic review and meta-analysis of randomized controlled trials","volume":"18","author":"Xun","year":"2023","journal-title":"Glob Heart"},{"key":"10.1016\/j.jacc.2025.05.007_bib339","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41746-024-01067-y","article-title":"Technology-supported behavior change interventions for reducing sodium intake in adults: a systematic review and meta-analysis","volume":"7","author":"Yan","year":"2024","journal-title":"NPJ Digit Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib340","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/bmj.297.6644.319","article-title":"Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion","volume":"297","year":"1988","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2025.05.007_bib341","doi-asserted-by":"crossref","first-page":"626S","DOI":"10.1093\/ajcn\/65.2.626S","article-title":"The INTERSALT study: background, methods, findings, and implications","volume":"65","author":"Stamler","year":"1997","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jacc.2025.05.007_bib342","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/HYPERTENSIONAHA.123.17959","article-title":"Salt sensitivity: causes, consequences, and recent advances","volume":"81","author":"Bailey","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib343","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1161\/HYPERTENSIONAHA.122.17952","article-title":"Salt sensitivity of blood pressure in women","volume":"80","author":"Barris","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib344","doi-asserted-by":"crossref","first-page":"Ii127","DOI":"10.1161\/01.HYP.8.6_Pt_2.II127","article-title":"Definitions and characteristics of sodium sensitivity and blood pressure resistance","volume":"8","author":"Weinberger","year":"1986","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib345","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/07315724.1991.10718167","article-title":"Relative contributions of dietary sodium sources","volume":"10","author":"Mattes","year":"1991","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.jacc.2025.05.007_bib346","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3390\/nu15040831","article-title":"Top sodium food sources in the American diet-using National Health and Nutrition Examination Survey","volume":"15","author":"Ahmed","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.jacc.2025.05.007_bib348","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1056\/NEJMoa0907355","article-title":"Projected effect of dietary salt reductions on future cardiovascular disease","volume":"362","author":"Bibbins-Domingo","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib349","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/jch.14562","article-title":"Effectiveness of salt substitute on cardiovascular outcomes: a systematic review and meta-analysis","volume":"24","author":"Tsai","year":"2022","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.jacc.2025.05.007_bib350","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1136\/heartjnl-2022-321332","article-title":"Effects of salt substitutes on clinical outcomes: a systematic review and meta-analysis","volume":"108","author":"Yin","year":"2022","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2025.05.007_bib351","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1161\/HYPERTENSIONAHA.120.15238","article-title":"Twenty-four-hour urinary sodium and potassium excretion and their associations with blood pressure among adults in China","volume":"76","author":"Li","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib352","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/advances\/nmab036","article-title":"Association between the urinary sodium to potassium ratio and blood pressure in adults: a systematic review and meta-analysis","volume":"12","author":"Ndanuko","year":"2021","journal-title":"Adv Nutr"},{"key":"10.1016\/j.jacc.2025.05.007_bib353","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1161\/HYPERTENSIONAHA.117.09928","article-title":"Relation of dietary sodium (salt) to blood pressure and its possible modulation by other dietary factors","volume":"71","author":"Stamler","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib354","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12916-024-03350-x","article-title":"Sex-specific associations between sodium and potassium intake and overall and cause-specific mortality: a large prospective U.S. cohort study, systematic review, and updated meta-analysis of cohort studies","volume":"22","author":"Gan","year":"2024","journal-title":"BMC Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib355","article-title":"Association between usual sodium and potassium intake and blood pressure and hypertension among U.S. adults: NHANES 2005-2010","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2025.05.007_bib356","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004210","article-title":"Meta-analysis of potassium intake and the risk of stroke","volume":"5","author":"Vinceti","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.05.007_bib357","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1161\/HYPERTENSIONAHA.124.22703","article-title":"Alcohol intake and risk of hypertension: a systematic review and dose-response meta-analysis of nonexperimental cohort studies","volume":"81","author":"Cecchini","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib358","first-page":"CD010022","article-title":"Alcohol intake reduction for controlling hypertension","volume":"9","author":"Acin","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2025.05.007_bib359","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/archinte.158.11.1197","article-title":"Prevention and Treatment of Hypertension Study (PATHS): effects of an alcohol treatment program on blood pressure","volume":"158","author":"Cushman","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib360","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/S2468-2667(22)00317-6","article-title":"Health and cancer risks associated with low levels of alcohol consumption","volume":"8","author":"Anderson","year":"2023","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.jacc.2025.05.007_bib361","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018487","article-title":"Exercise reduces ambulatory blood pressure in patients with hypertension: a systematic review and meta-analysis of randomized controlled trials","volume":"9","author":"Saco-Ledo","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.05.007_bib362","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2023.112193","article-title":"Chronic effect of resistance training on blood pressure in older adults with prehypertension and hypertension: a systematic review and meta-analysis","volume":"177","author":"Henkin","year":"2023","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.jacc.2025.05.007_bib363","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003231","article-title":"Dynamic resistance training as stand-alone antihypertensive lifestyle therapy: a meta-analysis","volume":"5","author":"MacDonald","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.05.007_bib364","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/hr.2015.111","article-title":"Isometric exercise training for blood pressure management: a systematic review and meta-analysis to optimize benefit","volume":"39","author":"Inder","year":"2016","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jacc.2025.05.007_bib365","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/bjsports-2021-104642","article-title":"Isometric exercise versus high-intensity interval training for the management of blood pressure: a systematic review and meta-analysis","volume":"56","author":"Edwards","year":"2022","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib366","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/s41440-021-00720-3","article-title":"The effectiveness and safety of isometric resistance training for adults with high blood pressure: a systematic review and meta-analysis","volume":"44","author":"Hansford","year":"2021","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jacc.2025.05.007_bib367","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.numecd.2014.04.011","article-title":"Breaking up prolonged sitting reduces resting blood pressure in overweight\/obese adults","volume":"24","author":"Larsen","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.jacc.2025.05.007_bib368","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1249\/MSS.0000000000000754","article-title":"Effects of standing and light-intensity activity on ambulatory blood pressure","volume":"48","author":"Zeigler","year":"2016","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.jacc.2025.05.007_bib369","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1097\/HJH.0000000000001101","article-title":"Interrupting prolonged sitting with brief bouts of light walking or simple resistance activities reduces resting blood pressure and plasma noradrenaline in type 2 diabetes","volume":"34","author":"Dempsey","year":"2016","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib370","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1249\/MSS.0000000000001315","article-title":"Breaks in sitting time: effects on continuously monitored glucose and blood pressure","volume":"49","author":"Bhammar","year":"2017","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.jacc.2025.05.007_bib371","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1161\/HYPERTENSIONAHA.118.12373","article-title":"Effect of Morning Exercise With or Without Breaks in Prolonged Sitting on Blood Pressure in Older Overweight\/Obese Adults","volume":"73","author":"Wheeler","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib372","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jash.2017.12.008","article-title":"Are there cardiometabolic benefits of low-intensity physical activity in at-risk adults?","volume":"12","author":"Egan","year":"2018","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib373","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/HJH.0b013e328322cf60","article-title":"Influence of exercise at lower and higher intensity on blood pressure and cardiovascular risk factors at older age","volume":"27","author":"Cornelissen","year":"2009","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib374","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1007\/s40279-018-0944-y","article-title":"Effects of high-intensity interval training versus moderate-intensity continuous training on blood pressure in adults with pre- to established hypertension: a systematic review and meta-analysis of randomized trials","volume":"48","author":"Costa","year":"2018","journal-title":"Sports Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib375","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1161\/HYP.0b013e318293645f","article-title":"Beyond medications and diet: alternative approaches to lowering blood pressure","volume":"61","author":"Brook","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib376","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1161\/01.cir.0000437740.48606.d1","article-title":"2013 AHA\/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Eckel","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib377","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11906-022-01182-9","article-title":"Sodium intake and risk of hypertension: a systematic review and dose-response meta-analysis of observational cohort studies","volume":"24","author":"Filippini","year":"2022","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.jacc.2025.05.007_bib378","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/HJH.0000000000003589","article-title":"Effects of adding exercise to usual care on blood pressure in patients with hypertension, type 2 diabetes, or cardiovascular disease: a systematic review with meta-analysis and trial sequential analysis","volume":"42","author":"Rijal","year":"2024","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib379","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib380","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(14)61212-5","article-title":"Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data","volume":"384","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib381","doi-asserted-by":"crossref","first-page":"627","DOI":"10.7326\/0003-4819-154-9-201105030-00008","article-title":"Individualized guidelines: the potential for increasing quality and reducing costs","volume":"154","author":"Eddy","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib382","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib383","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002538","article-title":"Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: a meta-analysis of individual participant data","volume":"15","author":"Karmali","year":"2018","journal-title":"PLoS Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib384","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002126","article-title":"Identifying individuals at risk for cardiovascular events across the spectrum of blood pressure levels","volume":"4","author":"Karmali","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.05.007_bib385","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.diabres.2012.05.002","article-title":"Effects of blood pressure lowering on cardiovascular outcomes in different cardiovascular risk groups among participants with type 2 diabetes","volume":"98","author":"van Dieren","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jacc.2025.05.007_bib386","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib387","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028762","article-title":"Stage 1 hypertension and the 10-year and lifetime risk of cardiovascular disease: a prospective real-world study","volume":"12","author":"Peng","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.05.007_bib388","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJMsa1616035","article-title":"Cost-effectiveness of intensive versus standard blood-pressure control","volume":"377","author":"Bress","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib389","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0140-6736(22)02603-4","article-title":"Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial","volume":"401","author":"He","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib390","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1056\/NEJMoa1600175","article-title":"Blood-pressure lowering in intermediate-risk persons without cardiovascular disease","volume":"374","author":"Lonn","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib391","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/S0140-6736(21)00590-0","article-title":"Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis","volume":"397","author":"Rahimi","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib392","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/jamacardio.2024.1449","article-title":"Multifaceted intensive blood pressure control model in older and younger individuals with hypertension: a randomized clinical trial","volume":"9","author":"Guo","year":"2024","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib393","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(24)01028-6","article-title":"Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial","volume":"404","author":"Liu","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib394","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028762","article-title":"Stage 1 hypertension and the 10-year and lifetime risk of cardiovascular disease: a prospective real-world study","volume":"12","author":"Peng","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.05.007_bib395","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib396","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMoa2111437","article-title":"Trial of intensive blood-pressure control in older patients with hypertension","volume":"385","author":"Zhang","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib397","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(21)01921-8","article-title":"Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis","volume":"398","author":"Rahimi","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib398","doi-asserted-by":"crossref","first-page":"184","DOI":"10.7326\/M14-0773","article-title":"Effects of blood pressure reduction in mild hypertension: a systematic review and meta-analysis","volume":"162","author":"Sundstr\u00f6m","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib399","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(14)61212-5","article-title":"Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data","volume":"384","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib400","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002538","article-title":"Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: a meta-analysis of individual participant data","volume":"15","author":"Karmali","year":"2018","journal-title":"PLoS Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib401","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/CIR.0000000000001191","article-title":"Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the American Heart Association","volume":"148","author":"Khan","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib402","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","article-title":"Development and validation of the American Heart Association\u2019s PREVENT equations","volume":"149","author":"Khan","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib403","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1001\/jamacardio.2024.2912","article-title":"Tailoring risk prediction models to local populations","volume":"9","author":"Zinzuwadia","year":"2024","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib404","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.38311","article-title":"External validation of the American Heart Association PREVENT cardiovascular disease risk equations","volume":"7","author":"Scheuermann","year":"2024","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.jacc.2025.05.007_bib405","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D\u2019Agostino","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib406","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/CIRCULATIONAHA.117.032582","article-title":"Potential US population impact of the 2017 ACC\/AHA high blood pressure guideline","volume":"137","author":"Muntner","year":"2018","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.jacc.2025.05.007_bib407","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004248","article-title":"Effectiveness of chlorthalidone plus amiloride for the prevention of hypertension: the PREVER-Prevention randomized clinical trial","volume":"5","author":"Fuchs","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.05.007_bib408","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0895-7061(95)00116-7","article-title":"Essential hypertension predicted by tracking of elevated blood pressure from childhood to adulthood: the Bogalusa Heart Study","volume":"8","author":"Bao","year":"1995","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib409","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/jamacardio.2019.0529","article-title":"Lifetime risks for hypertension by contemporary guidelines in African American and White men and women","volume":"4","author":"Chen","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib410","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1161\/HYPERTENSIONAHA.120.15650","article-title":"Association of cumulative systolic blood pressure with long-term risk of cardiovascular disease and healthy longevity: findings from the lifetime risk pooling project cohorts","volume":"77","author":"Reges","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib411","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/jama.2013.285122","article-title":"Blood pressure trajectories in early adulthood and subclinical atherosclerosis in middle age","volume":"311","author":"Allen","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib412","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1161\/CIRCIMAGING.112.000450","article-title":"Longitudinal determinants of left ventricular mass and geometry: the Coronary Artery Risk Development in Young Adults (CARDIA) study","volume":"6","author":"Gidding","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2025.05.007_bib413","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1161\/CIRCULATIONAHA.116.025471","article-title":"Coronary artery calcium to guide a personalized risk-based approach to initiation and intensification of antihypertensive therapy","volume":"135","author":"McEvoy","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib414","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1161\/CIRCULATIONAHA.119.043337","article-title":"Incorporation of biomarkers into risk assessment for allocation of antihypertensive medication according to the 2017 ACC\/AHA high blood pressure guideline: a pooled cohort analysis","volume":"140","author":"Pandey","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib415","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1001\/jamacardio.2019.1746","article-title":"Association of conventional cardiovascular risk factors with cardiovascular disease after hypertensive disorders of pregnancy: analysis of the Nord-Tr\u00f8ndelag Health study","volume":"4","author":"Haug","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib416","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1161\/CIR.0000000000001078","article-title":"Life\u2019s essential 8: updating and enhancing the American Heart Association\u2019s construct of cardiovascular health: a presidential advisory from the American Heart Association","volume":"146","author":"Lloyd-Jones","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib417","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/HJH.0000000000000447","article-title":"Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs\u2014overview and meta-analyses","volume":"33","author":"Thomopoulos","year":"2015","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib418","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.21618","article-title":"Comparison of cardiovascular events among users of different classes of antihypertension medications: a systematic review and network meta-analysis","volume":"3","author":"Wei","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2025.05.007_bib419","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1741-7015-10-33","article-title":"Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysis","volume":"10","author":"Fretheim","year":"2012","journal-title":"BMC Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib420","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/HJH.0b013e32834000be","article-title":"The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials","volume":"29","author":"Czernichow","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib421","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2025.05.007_bib422","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib423","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1097\/HJH.0000000000000614","article-title":"Effects of blood pressure-lowering on outcome incidence in hypertension: 5. head-to-head comparisons of various classes of antihypertensive drugs - overview and meta-analyses","volume":"33","author":"Thomopoulos","year":"2015","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib424","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2025.05.007_bib425","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1056\/NEJMoa2212270","article-title":"Chlorthalidone vs. hydrochlorothiazide for hypertension-cardiovascular events","volume":"387","author":"Ishani","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib426","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib427","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib428","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/HYPERTENSIONAHA.120.15781","article-title":"Adherence to single-pill versus free-equivalent combination therapy in hypertension: a systematic review and meta-analysis","volume":"77","author":"Parati","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib429","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.amjmed.2008.09.038","article-title":"Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials","volume":"122","author":"Wald","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib430","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/jamacardio.2023.0720","article-title":"Efficacy and safety of low-dose triple and quadruple combination pills vs monotherapy, usual care, or placebo for the initial management of hypertension: a systematic review and meta-analysis","volume":"8","author":"Wang","year":"2023","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib431","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1161\/HYPERTENSIONAHA.122.20810","article-title":"Improved persistence to medication, decreased cardiovascular events and reduced all-cause mortality in hypertensive patients with use of single-pill combinations: results from the START-Study","volume":"80","author":"Schmieder","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib432","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002584","article-title":"Fixed-dose combination antihypertensive medications, adherence, and clinical outcomes: a population-based retrospective cohort study","volume":"15","author":"Verma","year":"2018","journal-title":"PLoS Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib433","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1001\/jama.2018.10359","article-title":"Fixed low-dose triple combination antihypertensive medication vs usual care for blood pressure control in patients with mild to moderate hypertension in Sri Lanka: a randomized clinical trial","volume":"320","author":"Webster","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib434","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1056\/NEJMoa1303154","article-title":"Combined angiotensin inhibition for the treatment of diabetic nephropathy","volume":"369","author":"Fried","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib435","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1056\/NEJMoa1208799","article-title":"Cardiorenal end points in a trial of aliskiren for type 2 diabetes","volume":"367","author":"Parving","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib436","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"Investigators","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib437","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1161\/HYP.0000000000000232","article-title":"Implementation strategies to improve blood pressure control in the United States: a scientific statement from the American Heart Association and American Medical Association","volume":"80","author":"Abdalla","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib438","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0140-6736(22)02603-4","article-title":"Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial","volume":"401","author":"He","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib439","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1136\/bmj.326.7404.1427","article-title":"Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials","volume":"326","author":"Law","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2025.05.007_bib440","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.amjmed.2006.08.033","article-title":"Fixed-dose combinations improve medication compliance: a meta-analysis","volume":"120","author":"Bangalore","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib441","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/jch.13272","article-title":"The impact of fixed-dose combination versus free-equivalent combination therapies on adherence for hypertension: a meta-analysis","volume":"20","author":"Du","year":"2018","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.jacc.2025.05.007_bib442","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.005624","article-title":"Clinic-based strategies to reach United States Million Hearts 2022 blood pressure control goals","volume":"12","author":"Bellows","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2025.05.007_bib443","doi-asserted-by":"crossref","first-page":"65S","DOI":"10.1177\/0272989X10378699","article-title":"Race, ethnicity, and shared decision making for hyperlipidemia and hypertension treatment: the DECISIONS survey","volume":"30","author":"Ratanawongsa","year":"2010","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jacc.2025.05.007_bib444","series-title":"Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Public Health Service","year":"1997"},{"key":"10.1016\/j.jacc.2025.05.007_bib446","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijcard.2016.04.082","article-title":"Impact of once- or twice-daily dosing frequency on adherence to chronic cardiovascular disease medications: a meta-regression analysis","volume":"216","author":"Weeda","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib447","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0149-2918(02)85026-3","article-title":"Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis","volume":"24","author":"Iskedjian","year":"2002","journal-title":"Clin Ther"},{"key":"10.1016\/j.jacc.2025.05.007_bib448","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/archinte.164.7.722","article-title":"How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials","volume":"164","author":"Schroeder","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib449","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/HYPERTENSIONAHA.109.139816","article-title":"Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis","volume":"55","author":"Gupta","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib450","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/jch.13272","article-title":"The impact of fixed-dose combination versus free-equivalent combination therapies on adherence for hypertension: a meta-analysis","volume":"20","author":"Du","year":"2018","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.jacc.2025.05.007_bib451","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1001\/jama.2018.10359","article-title":"Fixed low-dose triple combination antihypertensive medication vs usual care for blood pressure control in patients with mild to moderate hypertension in Sri Lanka: a randomized clinical trial","volume":"320","author":"Webster","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib452","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-075840","article-title":"Investigating the ability to adhere to cardiometabolic medications with different properties: a retrospective cohort study of >500 000 patients in the USA","volume":"13","author":"Lauffenburger","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.jacc.2025.05.007_bib453","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1016\/j.japh.2021.02.005","article-title":"The impact of medication synchronization programs on medication adherence: a meta-analysis","volume":"61","author":"Nsiah","year":"2021","journal-title":"J Am Pharm Assoc (2003)"},{"key":"10.1016\/j.jacc.2025.05.007_bib454","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/jcpt.12554","article-title":"The impact of appointment-based medication synchronization on medication taking behaviour and health outcomes: a systematic review","volume":"42","author":"Nguyen","year":"2017","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.jacc.2025.05.007_bib455","doi-asserted-by":"crossref","DOI":"10.2196\/24190","article-title":"Mobile apps to improve medication adherence in cardiovascular disease: systematic review and meta-analysis","volume":"23","author":"Al-Arkee","year":"2021","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.jacc.2025.05.007_bib456","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1001\/jamainternmed.2016.9627","article-title":"Effect of reminder devices on medication adherence: the REMIND randomized clinical trial","volume":"177","author":"Choudhry","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib457","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.3390\/ijerph18062882","article-title":"Is mindfulness-based stress reduction effective for people with hypertension? A systematic review and meta-analysis of 30 years of evidence","volume":"18","author":"Conversano","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jacc.2025.05.007_bib458","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/jamainternmed.2018.0447","article-title":"Association of a smartphone application with medication adherence and blood pressure control: the MedISAFE-BP randomized clinical trial","volume":"178","author":"Morawski","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib459","doi-asserted-by":"crossref","DOI":"10.1111\/ijn.12920","article-title":"Effects of self-management programs on blood pressure, self-efficacy, medication adherence and body mass index in older adults with hypertension: meta-analysis of randomized controlled trials","volume":"27","author":"Van Truong","year":"2021","journal-title":"Int J Nurs Pract"},{"key":"10.1016\/j.jacc.2025.05.007_bib460","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1177\/0897190020903573","article-title":"Pharmacist interventions in the management of blood pressure control and adherence to antihypertensive medications: a systematic review of randomized controlled trials","volume":"34","author":"Reeves","year":"2021","journal-title":"J Pharm Pract"},{"key":"10.1016\/j.jacc.2025.05.007_bib461","doi-asserted-by":"crossref","DOI":"10.2196\/21759","article-title":"The effect of smartphone app-based interventions for patients with hypertension: systematic review and meta-analysis","volume":"8","author":"Xu","year":"2020","journal-title":"JMIR Mhealth Uhealth"},{"key":"10.1016\/j.jacc.2025.05.007_bib462","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005641","article-title":"Nonadherence to antihypertensive drugs: a systematic review and meta-analysis","volume":"96","author":"Abegaz","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jacc.2025.05.007_bib463","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026582","article-title":"Global burden, regional differences, trends, and health consequences of medication nonadherence for hypertension during 2010 to 2020: a meta-analysis involving 27 million patients","volume":"11","author":"Lee","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.05.007_bib464","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jacc.2013.10.067","article-title":"Therapeutic drug monitoring facilitates blood pressure control in resistant hypertension","volume":"63","author":"Brinker","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib465","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jash.2015.04.004","article-title":"Comparison of Morisky Medication Adherence Scale with therapeutic drug monitoring in apparent treatment-resistant hypertension","volume":"9","author":"Pandey","year":"2015","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib466","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/HYP.0000000000000203","article-title":"Medication adherence and blood pressure control: a scientific statement from the American Heart Association","volume":"79","author":"Choudhry","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib467","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/HJH.0000000000003585","article-title":"Antihypertensive drug concentration measurement combined with personalized feedback in resistant hypertension: a randomized controlled trial","volume":"42","author":"Peeters","year":"2024","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib468","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ijcard.2016.01.069","article-title":"Non-adherence to antihypertensive medication: the role of mental and physical comorbidity","volume":"207","author":"Calder\u00f3n-Larra\u00f1aga","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib469","doi-asserted-by":"crossref","first-page":"97","DOI":"10.18865\/ed.31.1.97","article-title":"Association of perceived stress and discrimination on medication adherence among diverse patients with uncontrolled hypertension","volume":"31","author":"Alvarez","year":"2021","journal-title":"Ethn Dis"},{"key":"10.1016\/j.jacc.2025.05.007_bib470","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ajh.2011.256","article-title":"Symptoms of depression and anxiety and adherence to antihypertensive medication","volume":"25","author":"Bautista","year":"2012","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib471","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020849","article-title":"Links between blood pressure and medication intake, well-being, stress, physical activity and symptoms reported via a mobile phone-based self-management support system: a cohort study in primary care","volume":"8","author":"Taft","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.jacc.2025.05.007_bib472","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5455\/msm.2024.36.65-72","article-title":"Unveiling the Nexus: depressive symptoms and medication adherence in hypertensive patients' self-care: a systematic review","volume":"36","author":"Stamoulis","year":"2024","journal-title":"Mater Sociomed"},{"key":"10.1016\/j.jacc.2025.05.007_bib473","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s12872-023-03357-x","article-title":"Prevalence of uncontrolled hypertension and its associated factors in 50-74 years old Iranian adults: a population-based study","volume":"23","author":"Farhadi","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jacc.2025.05.007_bib474","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0290692","article-title":"Demographic and socioeconomic determinants of access to care: a subgroup disparity analysis using new equity-focused measurements","volume":"18","author":"Qi","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2025.05.007_bib475","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-039940","article-title":"Assessment of patient and provider attitudes towards therapeutic drug monitoring to improve medication adherence in low-income patients with hypertension: a qualitative study","volume":"10","author":"Schesing","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.jacc.2025.05.007_bib476","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(22)01786-X","article-title":"Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial","volume":"400","author":"Mackenzie","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib477","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41371-022-00764-z","article-title":"A systematic review and meta-analysis of mindfulness-based stress reduction for arterial hypertension","volume":"37","author":"Geiger","year":"2023","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib478","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1161\/HYPERTENSIONAHA.120.16160","article-title":"Effect and acceptability of mindfulness-based stress reduction program on patients with elevated blood pressure or hypertension: a meta-analysis of randomized controlled trials","volume":"76","author":"Lee","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib479","article-title":"Providing physicians with feedback on medication adherence for people with chronic diseases taking long-term medication","volume":"1","author":"Zaugg","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2025.05.007_bib480","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11906-021-01131-y","article-title":"Drug interactions with antihypertensives","volume":"23","author":"Fravel","year":"2021","journal-title":"Curr Hypertens Rep"},{"issue":"11","key":"10.1016\/j.jacc.2025.05.007_bib481","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1161\/HYPERTENSIONAHA.124.23597","article-title":"Optimal antihypertensive systolic blood pressure: a systematic review and meta-analysis","volume":"81","author":"Whelton","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib482","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMoa2111437","article-title":"Trial of intensive blood-pressure control in older patients with hypertension","volume":"385","author":"Zhang","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib483","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1056\/NEJMoa2412006","article-title":"Intensive blood-pressure control in patients with type 2 diabetes (BPROAD)","volume":"392","author":"Bi","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib484","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(24)01028-6","article-title":"Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial","volume":"404","author":"Liu","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib485","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004248","article-title":"Effectiveness of chlorthalidone plus amiloride for the prevention of hypertension: the PREVER-Prevention randomized clinical trial","volume":"5","author":"Fuchs","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.05.007_bib486","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0140-6736(22)02603-4","article-title":"Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial","volume":"401","author":"He","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib487","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib488","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/S0140-6736(14)60685-1","article-title":"Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people","volume":"383","author":"Rapsomaniki","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib489","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1001\/jamacardio.2020.1731","article-title":"Association of normal systolic blood pressure level with cardiovascular disease in the absence of risk factors","volume":"5","author":"Whelton","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib490","article-title":"Intensive blood-pressure control in patients with type 2 diabetes","author":"Bi","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib491","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib492","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(13)60852-1","article-title":"Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial","volume":"382","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib493","doi-asserted-by":"crossref","first-page":"E116","DOI":"10.1161\/HYP.0000000000000067","volume":"71","author":"Reboussin","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib494","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1056\/NEJMoa1901281","article-title":"Final report of a trial of intensive versus standard blood-pressure control","volume":"384","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib495","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1001\/jamaneurol.2019.2167","article-title":"Effect of standard vs intensive blood pressure control on the risk of recurrent stroke: a randomized clinical trial and meta-analysis","volume":"76","author":"Kitagawa","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jacc.2025.05.007_bib496","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/HJH.0000000000000447","article-title":"Effects of blood pressure lowering on outcome incidence in hypertension: effects of various classes of antihypertensive drugs-overview and meta-analyses","volume":"33","author":"Thomopoulos","year":"2015","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib497","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/S0140-6736(21)00590-0","article-title":"Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis","volume":"397","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib498","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/jamacardio.2017.1421","article-title":"Systolic blood pressure reduction and risk of cardiovascular disease and mortality: a systematic review and network meta-analysis","volume":"2","author":"Bundy","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib499","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1161\/HYPERTENSIONAHA.116.07608","article-title":"More versus less intensive blood pressure-lowering strategy: cumulative evidence and trial sequential analysis","volume":"68","author":"Verdecchia","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib500","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.amjmed.2017.01.004","article-title":"Optimal systolic blood pressure target after SPRINT: insights from a network meta-analysis of randomized trials","volume":"130","author":"Bangalore","year":"2017","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib501","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib502","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1161\/CIRCULATIONAHA.117.030848","article-title":"Influence of baseline diastolic blood pressure on effects of intensive compared with standard blood pressure control","volume":"137","author":"Beddhu","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib503","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1161\/HYP.0000000000000195","article-title":"Management of stage 1 hypertension in adults with a low 10-year risk for cardiovascular disease: filling a guidance gap: a scientific statement from the American Heart Association","volume":"77","author":"Jones","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib504","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1056\/NEJMoa1303154","article-title":"Combined angiotensin inhibition for the treatment of diabetic nephropathy","volume":"369","author":"Fried","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib505","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"Investigators","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib506","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa032292","article-title":"Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both","volume":"349","author":"Pfeffer","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib507","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1007\/s12325-023-02518-w","article-title":"Real-world modifications of renin-angiotensin-aldosterone system inhibitors in patients with hyperkalemia initiating sodium zirconium cyclosilicate therapy: the OPTIMIZE I study","volume":"40","author":"Agiro","year":"2023","journal-title":"Adv Ther"},{"key":"10.1016\/j.jacc.2025.05.007_bib508","doi-asserted-by":"crossref","first-page":"798","DOI":"10.2215\/CJN.12651018","article-title":"Sodium zirconium cyclosilicate among individuals with hyperkalemia: a 12-month phase 3 study","volume":"14","author":"Spinowitz","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jacc.2025.05.007_bib509","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1002\/ejhf.2635","article-title":"Effects of steroidal mineralocorticoid receptor antagonists on acute and chronic estimated glomerular filtration rate slopes in patients with chronic heart failure","volume":"24","author":"Vaduganathan","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.05.007_bib510","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10157-023-02413-2","article-title":"The role of a novel mineralocorticoid receptor antagonist, finerenone, in chronic kidney disease: mechanisms and clinical advances","volume":"28","author":"Chen","year":"2024","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.jacc.2025.05.007_bib511","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1161\/HYPERTENSIONAHA.111.173195","article-title":"Aldosterone blunts tubuloglomerular feedback by activating macula densa mineralocorticoid receptors","volume":"59","author":"Fu","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib512","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/ki.2011.79","article-title":"An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function","volume":"80","author":"Holtkamp","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacc.2025.05.007_bib513","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/archinte.160.5.685","article-title":"Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?","volume":"160","author":"Bakris","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib514","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/ki.1997.111","article-title":"A short-term antihypertensive treatment-induced fall in glomerular filtration rate predicts long-term stability of renal function","volume":"51","author":"Apperloo","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacc.2025.05.007_bib515","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib516","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0140-6736(98)04433-X","article-title":"Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial","volume":"352","author":"Ruggenenti","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib517","first-page":"489","article-title":"Renal effects and associated outcomes during angiotensin-neprilysin inhibition in heart failure","volume":"6","author":"Damman","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib518","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/ejhf.1697","article-title":"Evaluation of kidney function throughout the heart failure trajectory-a position statement from the Heart Failure Association of the European Society of Cardiology","volume":"22","author":"Mullens","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.05.007_bib519","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1161\/HYPERTENSIONAHA.121.18502","article-title":"Hypertension-mediated organ damage: prevalence, correlates, and prognosis in the community","volume":"79","author":"Vasan","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib520","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1097\/HJH.0000000000002063","article-title":"High-normal blood pressure and abnormal left ventricular geometric patterns: a meta-analysis","volume":"37","author":"Cuspidi","year":"2019","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib521","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/ehjci\/jex094","volume":"18","author":"Perrone-Filardi","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2025.05.007_bib522","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/S0140-6736(14)60685-1","article-title":"Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people","volume":"383","author":"Rapsomaniki","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib523","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/01.CIR.77.3.504","article-title":"Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial","volume":"77","author":"Rutan","year":"1988","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib524","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2143\/AC.59.4.2005202","article-title":"Recent insights in the development of organ damage caused by hypertension","volume":"59","author":"Persu","year":"2004","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib525","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/jama.2013.285122","article-title":"Blood pressure trajectories in early adulthood and subclinical atherosclerosis in middle age","volume":"311","author":"Allen","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib526","doi-asserted-by":"crossref","first-page":"91","DOI":"10.7326\/0003-4819-149-2-200807150-00005","article-title":"Prehypertension during young adulthood and coronary calcium later in life","volume":"149","author":"Pletcher","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib527","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/CIRCULATIONAHA.113.001614","article-title":"Combined effects of child and adult elevated blood pressure on subclinical atherosclerosis: the International Childhood Cardiovascular Cohort Consortium","volume":"128","author":"Juhola","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib528","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41371-018-0114-6","article-title":"Pre-hypertension and subclinical carotid damage: a meta-analysis","volume":"33","author":"Cuspidi","year":"2019","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib529","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oead102","article-title":"Hypertension-mediated organ damage involving multiple sites is an independent risk factor for cardiovascular events","volume":"3","author":"Lembo","year":"2023","journal-title":"Eur Heart J Open"},{"key":"10.1016\/j.jacc.2025.05.007_bib530","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1161\/HYPERTENSIONAHA.121.18786","article-title":"Interrelations between high blood pressure, organ damage, and cardiovascular disease: no more room for doubt","volume":"79","author":"Suvila","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib531","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib532","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1161\/HYPERTENSIONAHA.118.12414","article-title":"Effects of blood pressure lowering on clinical outcomes according to baseline blood pressure and cardiovascular risk in patients with type 2 diabetes mellitus","volume":"73","author":"Rahman","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib533","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jama.2014.18574","article-title":"Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis","volume":"313","author":"Emdin","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib534","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008277.pub2","article-title":"Blood pressure targets for hypertension in people with diabetes mellitus","author":"Arguedas","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2025.05.007_bib535","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/HYPERTENSIONAHA.123.20954","article-title":"Systolic blood pressure control targets to prevent major cardiovascular events and death in patients with type 2 diabetes: a systematic review and network meta-analysis","volume":"80","author":"Yang","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib536","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1056\/NEJMoa2412006","article-title":"Intensive blood-pressure control in patients with type 2 diabetes (BPROAD)","volume":"392","author":"Bi","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib537","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"HOT Study Group. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib538","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/archinte.165.12.1401","article-title":"Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"165","author":"Whelton","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib539","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1046\/j.1523-1755.2003.00885.x","article-title":"The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study","volume":"63","author":"Keane","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacc.2025.05.007_bib540","first-page":"CD006257","article-title":"Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease","volume":"2006","author":"Strippoli","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2025.05.007_bib541","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(14)62459-4","article-title":"Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis","volume":"385","author":"Palmer","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib542","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(07)60242-6","article-title":"Renin-angiotensin system and cardiovascular risk","volume":"369","author":"Schmieder","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib543","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.ajkd.2003.07.015","article-title":"Progression of renal insufficiency in type 2 diabetes with and without microalbuminuria: results of the Heart Outcomes and Prevention Evaluation (HOPE) randomized study","volume":"42","author":"Mann","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacc.2025.05.007_bib544","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/0002-8703(91)90432-H","article-title":"The epidemiology of impaired glucose tolerance and hypertension","volume":"121","author":"Kannel","year":"1991","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2025.05.007_bib545","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2337\/diacare.16.2.434","article-title":"Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial","volume":"16","author":"Stamler","year":"1993","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2025.05.007_bib546","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib547","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib548","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s12020-023-03636-9","article-title":"The effect of semaglutide on blood pressure in patients with type-2 diabetes: a systematic review and meta-analysis","volume":"83","author":"Wu","year":"2024","journal-title":"Endocrine"},{"key":"10.1016\/j.jacc.2025.05.007_bib549","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1161\/CIRCULATIONAHA.105.592733","article-title":"Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial","volume":"114","author":"Solomon","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib550","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib551","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib552","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1001\/jama.2021.23619","article-title":"Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: the STEP 8 randomized clinical trial","volume":"327","author":"Rubino","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib553","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1001\/jama.2021.1831","article-title":"Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: the STEP 3 randomized clinical trial","volume":"325","author":"Wadden","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib554","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1161\/HYPERTENSIONAHA.123.22022","article-title":"Tirzepatide reduces 24-hour ambulatory blood pressure in adults with body mass index\u2265 27 kg\/m2: SURMOUNT-1 ambulatory blood pressure monitoring substudy","volume":"81","author":"de Lemos","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib555","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jacc.2023.11.032","article-title":"Randomized trial of effect of bariatric surgery on blood pressure after 5 years","volume":"83","author":"Schiavon","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib556","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jacc.2010.05.034","article-title":"The metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis","volume":"56","author":"Mottillo","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib557","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","article-title":"A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib558","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib559","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1161\/CIR.0000000000001209","article-title":"2024 Heart disease and stroke statistics: a report of US and global data from the American Heart Association","volume":"149","author":"Martin","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib560","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1001\/jama.2021.3224","article-title":"Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial","volume":"325","author":"Rubino","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib561","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1001\/jama.2018.14433","article-title":"Comparison of the performance of common measures of weight regain after bariatric surgery for association with clinical outcomes","volume":"320","author":"King","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib562","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1097\/01.hjh.0000938980.77721.18","article-title":"The effect of semaglutide on blood pressure in patients without diabetes: a systematic review and meta-analysis","volume":"41","author":"Kennedy","year":"2023","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib563","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa2114833","article-title":"Calorie restriction with or without time-restricted eating in weight loss","volume":"386","author":"Liu","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib564","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1056\/NEJMoa1700459","article-title":"Weight and metabolic outcomes 12 years after gastric bypass","volume":"377","author":"Adams","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib565","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/HYPERTENSIONAHA.117.10786","article-title":"Hypertension, microvascular pathology, and prognosis after an acute myocardial infarction","volume":"72","author":"Carrick","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib566","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"Sprint Research Group. A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib567","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/jamacardio.2017.1421","article-title":"Systolic blood pressure reduction and risk of cardiovascular disease and mortality: a systematic review and network meta-analysis","volume":"2","author":"Bundy","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib568","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1056\/NEJMoa1901281","article-title":"Sprint Research Group. Final report of a trial of intensive versus standard blood-pressure control","volume":"384","author":"Lewis","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib569","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jacc.2023.04.003","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"83","author":"Virani","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib570","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1093\/eurheartj\/ehy287","article-title":"Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120-140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials","volume":"39","author":"B\u00f6hm","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.05.007_bib571","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2025.05.007_bib572","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1056\/NEJMoa2401479","article-title":"Beta-blockers after myocardial infarction and preserved ejection fraction (REDUCE-AMI)","volume":"390","author":"Yndigegn","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib573","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1097\/MJT.0000000000000369","article-title":"Efficacy of calcium channel blockers versus other classes of antihypertensive medication in the treatment of hypertensive patients with previous stroke and\/or coronary artery disease: a systematic review and meta-analysis","volume":"24","author":"Jeffers","year":"2017","journal-title":"Am J Ther"},{"key":"10.1016\/j.jacc.2025.05.007_bib574","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/01.hjh.0000160223.94220.29","article-title":"Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension: the ACTION trial","volume":"23","author":"Lubsen","year":"2005","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib576","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1503\/cmaj.121468","article-title":"Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis","volume":"185","author":"Lv","year":"2013","journal-title":"CMAJ"},{"key":"10.1016\/j.jacc.2025.05.007_bib577","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejim.2022.03.032","article-title":"Benefits of more intensive versus less intensive blood pressure control. Updated trial sequential analysis","volume":"101","author":"Reboldi","year":"2022","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib578","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/HJH.0000000000000881","article-title":"Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels - updated overview and meta-analyses of randomized trials","volume":"34","author":"Thomopoulos","year":"2016","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib579","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0140-6736(15)00805-3","article-title":"Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis","volume":"387","author":"Xie","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib580","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2023.102131","article-title":"Association of low diastolic blood pressure with cardiovascular outcomes and all-cause mortality: a meta-analysis","volume":"49","author":"Siddiqi","year":"2024","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib581","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/eurjpc\/zwad344","article-title":"Blood pressure, hypertension, and the risk of heart failure: a systematic review and meta-analysis of cohort studies","volume":"31","author":"Baffour","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib582","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa0807265","article-title":"Racial differences in incident heart failure among young adults","volume":"360","author":"Bibbins-Domingo","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib583","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1001\/jama.1970.03170330025003","article-title":"Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg","volume":"213","year":"1970","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib584","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1001\/jama.1997.03550030052033","article-title":"SHEP Cooperative Research Group. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension","volume":"278","author":"Kostis","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib585","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2025.05.007_bib586","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1097\/HJH.0000000000002523","article-title":"Beta-blockers in hypertension: overview and meta-analysis of randomized outcome trials","volume":"38","author":"Thomopoulos","year":"2020","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib587","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"Sprint Research Group. A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib588","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.016782","article-title":"Trends of clinical outcomes and health care resource use in heart failure in the United States","volume":"9","author":"Khan","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.05.007_bib589","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/CIRCULATIONAHA.108.845792","article-title":"The progression of hypertensive heart disease","volume":"123","author":"Drazner","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib590","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1056\/NEJM198808183190701","article-title":"The effect of diltiazem on mortality and reinfarction after myocardial infarction","volume":"319","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib591","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/01.CIR.83.1.52","article-title":"Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction","volume":"83","author":"Goldstein","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib592","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib593","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib594","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.jacc.2023.03.393","article-title":"2023 ACC expert consensus decision pathway on management of heart failure with preserved ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"81","author":"Kittleson","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib595","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib596","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib597","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.pcad.2020.04.003","article-title":"Control of 24-hour blood pressure with SGLT2 inhibitors to prevent cardiovascular disease","volume":"63","author":"Kario","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.jacc.2025.05.007_bib598","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13098-023-01092-z","article-title":"Efficacy and safety evaluation of SGLT2i on blood pressure control in patients with type 2 diabetes and hypertension: a new meta-analysis","volume":"15","author":"Zhang","year":"2023","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.jacc.2025.05.007_bib599","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"83","author":"Joglar","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib600","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCULATIONAHA.110.009035","article-title":"Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study","volume":"123","author":"Huxley","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib601","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/CIRCRESAHA.117.311402","article-title":"Hypertension and atrial fibrillation: doubts and certainties from basic and clinical studies","volume":"122","author":"Verdecchia","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2025.05.007_bib602","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/CIRCRESAHA.120.316340","article-title":"Epidemiology of atrial fibrillation in the 21st century: novel methods and new insights","volume":"127","author":"Kornej","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2025.05.007_bib603","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1161\/HYPERTENSIONAHA.120.14766","article-title":"Effect of intensive blood pressure lowering on the risk of atrial fibrillation","volume":"75","author":"Soliman","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib604","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/europace\/euv021","article-title":"Effect of antihypertensive agents on risk of atrial fibrillation: a meta-analysis of large-scale randomized trials","volume":"17","author":"Emdin","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2025.05.007_bib605","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003599","article-title":"Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: an individual participant data meta-analysis","volume":"18","author":"Pinho-Gomes","year":"2021","journal-title":"PLoS Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib606","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/HYPERTENSIONAHA.122.19459","article-title":"Atrial fibrillation detection and management in hypertension","volume":"80","author":"Gawalko","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib607","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijcard.2016.12.029","article-title":"Aldosterone pathway blockade to prevent atrial fibrillation: a systematic review and meta-analysis","volume":"231","author":"Neefs","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib608","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.jacc.2020.11.018","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"77","author":"Otto","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib609","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1161\/01.HYP.0000070029.30058.59","article-title":"Symptomatic aortic stenosis: does systemic hypertension play an additional role?","volume":"41","author":"Antonini-Canterin","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib610","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/HJH.0b013e328332fa44","article-title":"Impact of hypertension on left ventricular structure in patients with asymptomatic aortic valve stenosis (a SEAS substudy)","volume":"28","author":"Rieck","year":"2010","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib611","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/ehjci\/jev043","article-title":"A prospective, double-blind, randomized controlled trial of the angiotensin-converting enzyme inhibitor Ramipril In Aortic Stenosis (RIAS trial)","volume":"16","author":"Bull","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2025.05.007_bib612","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jacc.2019.10.047","article-title":"Diastolic blood pressure and heart rate are independently associated with mortality in chronic aortic regurgitation","volume":"75","author":"Yang","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib613","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/heartjnl-2017-311738","article-title":"Renin-angiotensin system blockade therapy after transcatheter aortic valve implantation","volume":"104","author":"Ochiai","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2025.05.007_bib614","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1136\/heartjnl-2015-309186","article-title":"Heartbeat: beta-blockers for aortic regurgitation","volume":"102","author":"Otto","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2025.05.007_bib615","doi-asserted-by":"crossref","first-page":"43","DOI":"10.21037\/atm.2017.11.30","article-title":"Hypertension, aortic stenosis, and aortic regurgitation","volume":"6","author":"Aronow","year":"2018","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib616","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/j.jacc.2011.07.043","article-title":"The impact of renin-angiotensin-aldosterone system blockade on heart failure outcomes and mortality in patients identified to have aortic regurgitation: a large population cohort study","volume":"58","author":"Elder","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib617","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/ajh\/hpaa183","article-title":"Central hypertension in patients with thoracic aortic aneurysms: prevalence and association with aneurysm size and growth","volume":"35","author":"Rooprai","year":"2022","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib618","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.3390\/ijerph15122805","article-title":"Risk factors for abdominal aortic aneurysm in population-based studies: a systematic review and meta-analysis","volume":"15","author":"Altobelli","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jacc.2025.05.007_bib619","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10654-019-00510-9","article-title":"Blood pressure, hypertension and the risk of abdominal aortic aneurysms: a systematic review and meta-analysis of cohort studies","volume":"34","author":"Kobeissi","year":"2019","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib620","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1161\/CIRCULATIONAHA.121.056546","article-title":"Blood pressure, hypertension, and the risk of aortic dissection incidence and mortality: results from the J-SCH Study, the UK Biobank Study, and a meta-analysis of cohort studies","volume":"145","author":"Hibino","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib621","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1253\/circj.CJ-18-0721","article-title":"Effect of hypertension on aortic artery disease-related mortality; 3.8-year nationwide community-based prospective cohort study","volume":"82","author":"Otaki","year":"2018","journal-title":"Circ J"},{"key":"10.1016\/j.jacc.2025.05.007_bib622","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/bjs.9838","article-title":"Age-specific incidence, risk factors and outcome of acute abdominal aortic aneurysms in a defined population","volume":"102","author":"Howard","year":"2015","journal-title":"Br J Surg"},{"key":"10.1016\/j.jacc.2025.05.007_bib623","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1001\/jamacardio.2022.3345","article-title":"Longer-term all-cause and cardiovascular mortality with intensive blood pressure control: a secondary analysis of a randomized clinical trial","volume":"7","author":"Jaeger","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib624","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/bjs.8707","article-title":"Meta-analysis of individual patient data to examine factors affecting growth and rupture of small abdominal aortic aneurysms","volume":"99","author":"Sweeting","year":"2012","journal-title":"Br J Surg"},{"key":"10.1016\/j.jacc.2025.05.007_bib625","doi-asserted-by":"crossref","first-page":"e223","DOI":"10.1016\/j.jacc.2022.08.004","article-title":"2022 ACC\/AHA guideline for the diagnosis and management of aortic disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"80","author":"Isselbacher","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib626","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib627","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1161\/HYPERTENSIONAHA.119.12697","article-title":"Mortality outcomes with intensive blood pressure targets in chronic kidney disease patients","volume":"73","author":"Aggarwal","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib628","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1001\/jamainternmed.2017.4377","article-title":"Association between more intensive vs less intensive blood pressure lowering and risk of mortality in chronic kidney disease stages 3 to 5: a systematic review and meta-analysis","volume":"177","author":"Malhotra","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib629","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1053\/j.ajkd.2015.10.011","article-title":"Renin-angiotensin system inhibitors and kidney and cardiovascular outcomes in patients with CKD: a bayesian network meta-analysis of randomized clinical trials","volume":"67","author":"Xie","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacc.2025.05.007_bib630","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f6008","article-title":"Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis","volume":"347","author":"Wu","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2025.05.007_bib631","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1161\/HYPERTENSIONAHA.109.129841","article-title":"Blood pressure control among persons without and with chronic kidney disease: US trends and risk factors 1999-2006","volume":"54","author":"Plantinga","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib632","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.amjmed.2017.01.004","article-title":"Optimal systolic blood pressure target after SPRINT: insights from a network meta-analysis of randomized trials","volume":"130","author":"Bangalore","year":"2017","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib633","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jacc.2013.10.050","article-title":"Angiotensin-converting enzyme inhibitor, angiotensin receptor blocker use, and mortality in patients with chronic kidney disease","volume":"63","author":"Molnar","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib634","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","article-title":"Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial","volume":"288","author":"Wright","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib635","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib636","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib637","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"Yusuf","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib638","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/ki.2011.79","article-title":"An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function","volume":"80","author":"Holtkamp","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacc.2025.05.007_bib639","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.kint.2016.09.038","article-title":"Acute change in glomerular filtration rate with inhibition of the renin-angiotensin system does not predict subsequent renal and cardiovascular outcomes","volume":"91","author":"Clase","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacc.2025.05.007_bib640","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.kint.2019.05.019","article-title":"Acute declines in estimated glomerular filtration rate on enalapril and mortality and cardiovascular outcomes in patients with heart failure with reduced ejection fraction","volume":"96","author":"McCallum","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacc.2025.05.007_bib641","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1056\/NEJMoa2210639","article-title":"Renin-angiotensin system inhibition in advanced chronic kidney disease","volume":"387","author":"Bhandari","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib642","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1056\/NEJMoa1303154","article-title":"Combined angiotensin inhibition for the treatment of diabetic nephropathy","volume":"369","author":"Fried","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib643","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(08)61236-2","article-title":"Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial","volume":"372","author":"Mann","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib644","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1053\/j.ajkd.2004.03.013","article-title":"Hypertension after kidney transplantation","volume":"43","author":"Kasiske","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacc.2025.05.007_bib645","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/ajh\/hpz095","article-title":"Blood pressure, chronic kidney disease progression, and kidney allograft failure in kidney transplant recipients: a secondary analysis of the FAVORIT trial","volume":"32","author":"Malhotra","year":"2019","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib646","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11906-021-01151-8","article-title":"Update on treatment of hypertension after renal transplantation","volume":"23","author":"Chatzikyrkou","year":"2021","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.jacc.2025.05.007_bib647","article-title":"Office or home versus 24-hour blood pressure measurement in stable kidney transplant recipients","volume":"28","author":"Eleftheriadis","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jacc.2025.05.007_bib648","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1399-0012.2004.00315.x","article-title":"Hypertension, antihypertensive agents and outcomes following renal transplantation","volume":"19","author":"Tutone","year":"2005","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jacc.2025.05.007_bib649","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1097\/HJH.0000000000003663","article-title":"Blood pressure lowering for kidney transplant recipients: systematic review with network meta-analysis","volume":"42","author":"Natale","year":"2024","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib650","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2215\/CJN.0000000000000439","article-title":"Effect of spironolactone on kidney function in kidney transplant recipients (the SPIREN trial): a randomized placebo-controlled clinical trial","volume":"19","author":"Mortensen","year":"2024","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jacc.2025.05.007_bib651","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1161\/CIR.0000000000001209","article-title":"2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association","volume":"149","author":"Martin","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib652","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1056\/NEJMoa1214609","article-title":"Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage","volume":"368","author":"Anderson","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib653","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(23)00806-1","article-title":"The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial","volume":"402","author":"Ma","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib654","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S1474-4422(19)30196-6","article-title":"Blood pressure control and clinical outcomes in acute intracerebral haemorrhage: a preplanned pooled analysis of individual participant data","volume":"18","author":"Moullaali","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jacc.2025.05.007_bib655","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S1474-4422(14)70018-3","article-title":"Blood pressure variability and outcome after acute intracerebral haemorrhage: a post-hoc analysis of INTERACT2, a randomised controlled trial","volume":"13","author":"Manning","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jacc.2025.05.007_bib656","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1212\/WNL.0000000000001205","article-title":"Optimal achieved blood pressure in acute intracerebral hemorrhage: INTERACT2","volume":"84","author":"Arima","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jacc.2025.05.007_bib657","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMoa1603460","article-title":"Intensive blood-pressure lowering in patients with acute cerebral hemorrhage","volume":"375","author":"Qureshi","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib658","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1001\/jamaneurol.2020.3075","article-title":"Outcomes of intensive systolic blood pressure reduction in patients with intracerebral hemorrhage and excessively high initial systolic blood pressure: post hoc analysis of a randomized clinical trial","volume":"77","author":"Qureshi","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jacc.2025.05.007_bib659","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1161\/CIR.0000000000001209","article-title":"2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association","volume":"149","author":"Martin","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib660","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/jnnp-2016-315346","article-title":"Intensive blood pressure lowering in patients with acute intracerebral haemorrhage: clinical outcomes and haemorrhage expansion. Systematic review and meta-analysis of randomised trials","volume":"88","author":"Boulouis","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jacc.2025.05.007_bib661","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1161\/STROKEAHA.119.026389","article-title":"Prehospital transdermal glyceryl trinitrate for ultra-acute intracerebral hemorrhage: data from the RIGHT-2 trial","volume":"50","author":"Bath","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2025.05.007_bib662","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/HJH.0000000000000414","article-title":"Low blood pressure during the acute period of ischemic stroke is associated with decreased survival","volume":"33","author":"Wohlfahrt","year":"2015","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib663","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1161\/01.STR.0000014509.11540.66","article-title":"Blood pressure and clinical outcomes in the International Stroke Trial","volume":"33","author":"Leonardi-Bee","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2025.05.007_bib664","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1365-2796.2003.01291.x","article-title":"U-shaped relationship between mortality and admission blood pressure in patients with acute stroke","volume":"255","author":"Vemmos","year":"2004","journal-title":"J Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib665","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","article-title":"Tissue plasminogen activator for acute ischemic stroke","volume":"333","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib666","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","article-title":"Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke","volume":"359","author":"Hacke","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib667","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1212\/WNL.0000000000013049","article-title":"Blood pressure after endovascular thrombectomy and outcomes in patients with acute ischemic stroke: an individual patient data meta-analysis","volume":"98","author":"Katsanos","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.jacc.2025.05.007_bib668","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1136\/neurintsurg-2019-015561","article-title":"Blood pressure reduction and outcome after endovascular therapy with successful reperfusion: a multicenter study","volume":"12","author":"Anadani","year":"2020","journal-title":"J Neurointerv Surg"},{"key":"10.1016\/j.jacc.2025.05.007_bib669","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-076448","article-title":"Early versus delayed antihypertensive treatment in patients with acute ischaemic stroke: multicentre, open label, randomised, controlled trial","volume":"383","author":"Liu","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2025.05.007_bib670","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0140-6736(19)30038-8","article-title":"Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial","volume":"393","author":"Anderson","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib671","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/jama.2013.282543","article-title":"Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke: the CATIS randomized clinical trial","volume":"311","author":"He","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib672","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(11)60104-9","article-title":"The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial","volume":"377","author":"Sandset","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib673","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/S0140-6736(22)01882-7","article-title":"Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2\/MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial","volume":"400","author":"Yang","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib674","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1001\/jama.2023.14590","article-title":"Intensive vs conventional blood pressure lowering after endovascular thrombectomy in acute ischemic stroke: the OPTIMAL-BP randomized clinical trial","volume":"330","author":"Nam","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib675","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jama.2023.14330","article-title":"Blood pressure management after endovascular therapy for acute ischemic stroke: the BEST-II randomized clinical trial","volume":"330","author":"Mistry","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib676","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ajem.2006.07.008","article-title":"Prevalence of elevated blood pressure in 563,704 adult patients with stroke presenting to the ED in the United States","volume":"25","author":"Qureshi","year":"2007","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib677","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1161\/01.STR.0000109769.22917.B0","article-title":"Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome","volume":"35","author":"Castillo","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2025.05.007_bib678","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(14)61121-1","article-title":"Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial","volume":"385","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib679","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000896","article-title":"Blood pressure reduction in the acute phase of an ischemic stroke does not improve short- or long-term dependency or mortality: a meta-analysis of current literature","volume":"94","author":"Zhao","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jacc.2025.05.007_bib680","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1179\/1743132813Y.0000000181","article-title":"Predictors of short-term improvement of ischemic stroke","volume":"35","author":"Muscari","year":"2013","journal-title":"Neurol Res"},{"key":"10.1016\/j.jacc.2025.05.007_bib681","article-title":"Parenteral fluid regimens for improving functional outcome in people with acute stroke","volume":"2015","author":"Visvanathan","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2025.05.007_bib682","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1111\/ene.13118","article-title":"Post-thrombolytic blood pressure and symptomatic intracerebral hemorrhage","volume":"23","author":"Waltimo","year":"2016","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jacc.2025.05.007_bib683","doi-asserted-by":"crossref","first-page":"78","DOI":"10.5853\/jos.2018.02369","article-title":"Association of elevated blood pressure levels with outcomes in acute ischemic stroke patients treated with intravenous thrombolysis: a systematic review and meta-analysis","volume":"21","author":"Malhotra","year":"2019","journal-title":"J Stroke"},{"key":"10.1016\/j.jacc.2025.05.007_bib684","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1161\/STROKEAHA.119.026889","article-title":"Blood pressure after endovascular therapy for ischemic stroke (BEST): a multicenter prospective cohort study","volume":"50","author":"Mistry","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2025.05.007_bib685","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.0179","article-title":"Intensive vs conventional blood pressure control after thrombectomy in acute ischemic stroke: a systematic review and meta-analysis","volume":"7","author":"Ghozy","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2025.05.007_bib686","article-title":"Blood pressure-lowering treatment for preventing recurrent stroke, major vascular events, and dementia in patients with a history of stroke or transient ischaemic attack","volume":"7","author":"Zonneveld","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2025.05.007_bib687","article-title":"Comparative effectiveness of blood pressure-lowering drugs in patients who have already suffered from stroke: traditional and Bayesian network meta-analysis of randomized trials","volume":"95","author":"Wang","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jacc.2025.05.007_bib688","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/HYPERTENSIONAHA.116.08485","article-title":"Blood pressure reduction and secondary stroke prevention: a systematic review and metaregression analysis of randomized clinical trials","volume":"69","author":"Katsanos","year":"2017","journal-title":"Hypertension (Dallas, TX: 1979)"},{"key":"10.1016\/j.jacc.2025.05.007_bib689","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(01)06178-5","article-title":"Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack","volume":"358","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib690","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1001\/jamaneurol.2019.2167","article-title":"Effect of standard vs intensive blood pressure control on the risk of recurrent stroke: a randomized clinical trial and meta-analysis","volume":"76","author":"Kitagawa","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jacc.2025.05.007_bib691","article-title":"Different systolic blood pressure targets for people with history of stroke or transient ischaemic attack: PAST-BP (Prevention After Stroke--Blood Pressure) randomised controlled trial","volume":"352","author":"Mant","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2025.05.007_bib692","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164608","article-title":"Intensive versus guideline blood pressure and lipid lowering in patients with previous stroke: main results from the pilot 'Prevention of Decline in Cognition after Stroke Trial' (PODCAST) randomised controlled trial","volume":"12","author":"Bath","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2025.05.007_bib693","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1161\/CIR.0000000000001209","article-title":"2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association","volume":"149","author":"Martin","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib694","doi-asserted-by":"crossref","first-page":"e1141","DOI":"10.1016\/S2214-109X(22)00238-8","article-title":"Hypertension in stroke survivors and associations with national premature stroke mortality: data for 2.5 million participants from multinational screening campaigns","volume":"10","author":"Lin","year":"2022","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.jacc.2025.05.007_bib695","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jocn.2018.10.026","article-title":"Impact of risk factors for recurrence after the first ischemic stroke in adults: a systematic review and meta-analysis","volume":"60","author":"Zheng","year":"2019","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.jacc.2025.05.007_bib696","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1001\/jama.2015.10082","article-title":"Association between blood pressure control and risk of recurrent intracerebral hemorrhage","volume":"314","author":"Biffi","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib697","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jash.2016.11.002","article-title":"Race-ethnicity on blood pressure control after ischemic stroke: a prospective cohort study","volume":"11","author":"Nguyen-Huynh","year":"2017","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib698","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1161\/STROKEAHA.112.663047","article-title":"Poor long-term blood pressure control after intracerebral hemorrhage","volume":"43","author":"Zahuranec","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2025.05.007_bib699","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1212\/WNL.0000000000005729","article-title":"Hypertension and intracerebral hemorrhage recurrence among White, Black, and Hispanic individuals","volume":"91","author":"Rodriguez-Torres","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.jacc.2025.05.007_bib700","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/hr.2009.139","article-title":"Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature","volume":"32","author":"Liu","year":"2009","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jacc.2025.05.007_bib701","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1161\/01.STR.0000166048.35740.a9","article-title":"Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention: principal results of a prospective randomized controlled study (MOSES)","volume":"36","author":"Schrader","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2025.05.007_bib702","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1097\/MJT.0000000000000369","article-title":"Efficacy of calcium channel blockers versus other classes of antihypertensive medication in the treatment of hypertensive patients with previous stroke and\/or coronary artery disease: a systematic review and meta-analysis","volume":"24","author":"Jeffers","year":"2017","journal-title":"Am J Ther"},{"key":"10.1016\/j.jacc.2025.05.007_bib703","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(13)60852-1","article-title":"Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial","volume":"382","author":"Benavente","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib704","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1056\/NEJMoa0804593","article-title":"Telmisartan to prevent recurrent stroke and cardiovascular events","volume":"359","author":"Yusuf","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib705","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1097\/HJH.0000000000000653","article-title":"Antihypertensive drug use and risk of cognitive decline in the very old: an observational study - the Newcastle 85+ Study","volume":"33","author":"Peters","year":"2015","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib706","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.2020.4249","article-title":"Association of blood pressure lowering with incident dementia or cognitive impairment: a systematic review and meta-analysis","volume":"323","author":"Hughes","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib707","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/jama.2018.21442","article-title":"Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial","volume":"321","author":"Williamson","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib708","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000213686","article-title":"Long-term effect of intensive vs standard blood pressure control on mild cognitive impairment and probable dementia in SPRINT","volume":"104","author":"Reboussin","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.jacc.2025.05.007_bib709","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-025-03616-8","article-title":"Effectiveness of blood pressure reduction on all-cause dementia among patients with hypertension: an open-label, blinded-endpoint, cluster-randomized trial","author":"He","year":"2025","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.jacc.2025.05.007_bib710","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/alz.13016","article-title":"2023 Alzheimer's disease facts and figures","volume":"19","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jacc.2025.05.007_bib987","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1212\/WNL.0000000000004826","article-title":"Practice guideline update summary: mild cognitive impairment: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology","volume":"90","author":"Petersen","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.jacc.2025.05.007_bib988","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1001\/archneur.59.11.1764","article-title":"Survival following a diagnosis of Alzheimer disease","volume":"59","author":"Brookmeyer","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jacc.2025.05.007_bib989","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s11906-022-01221-5","article-title":"Effects of hypertension on Alzheimer's disease and related disorders","volume":"24","author":"Malone","year":"2022","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.jacc.2025.05.007_bib990","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S1474-4422(21)00248-9","article-title":"Heart health meets cognitive health: evidence on the role of blood pressure","volume":"20","author":"Palta","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jacc.2025.05.007_bib991","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1001\/jama.2016.7050","article-title":"Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged >\/=75 years: a randomized clinical trial","volume":"315","author":"Williamson","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib992","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jalz.2018.07.222","article-title":"Vascular dysfunction-the disregarded partner of Alzheimer's disease","volume":"15","author":"Sweeney","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jacc.2025.05.007_bib993","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1016\/j.jacc.2019.04.034","article-title":"Vascular cognitive impairment and dementia: JACC Scientific Expert Panel","volume":"73","author":"Iadecola","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib994","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1161\/01.STR.27.8.1274","article-title":"Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study","volume":"27","author":"Longstreth","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2025.05.007_bib995","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1111\/ene.15716","article-title":"Association of regional white matter hyperintensities with hypertension and cognition in the population-based 1000BRAINS study","volume":"30","author":"Gronewold","year":"2023","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jacc.2025.05.007_bib996","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1177\/0300060519858023","article-title":"Volume of white matter hyperintensities increases with blood pressure in patients with hypertension","volume":"47","author":"Zhao","year":"2019","journal-title":"J Int Med Res"},{"key":"10.1016\/j.jacc.2025.05.007_bib997","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1136\/svn-2021-001357","article-title":"White matter hyperintensity progression is associated with incident probable dementia or mild cognitive impairment","volume":"7","author":"de Havenon","year":"2022","journal-title":"Stroke Vasc Neurol"},{"key":"10.1016\/j.jacc.2025.05.007_bib998","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1474-4422(05)70141-1","article-title":"The age-dependent relation of blood pressure to cognitive function and dementia","volume":"4","author":"Qiu","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jacc.2025.05.007_bib999","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1212\/WNL.56.12.1683","article-title":"Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study","volume":"56","author":"Kivipelto","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jacc.2025.05.007_bib1000","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.33353","article-title":"Use of antihypertensives, blood pressure, and estimated risk of dementia in late life: an individual participant data meta-analysis","volume":"6","author":"Lennon","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2025.05.007_bib1001","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.1093\/eurheartj\/ehac584","article-title":"Blood pressure lowering and prevention of dementia: an individual patient data meta-analysis","volume":"43","author":"Peters","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.05.007_bib1002","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(97)05381-6","article-title":"Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators","volume":"350","author":"Staessen","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib1003","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1161\/HYPERTENSIONAHA.109.140624","article-title":"Impact of blood pressure lowering on cardiovascular outcomes in normal weight, overweight, and obese individuals: the Perindopril Protection Against Recurrent Stroke Study trial","volume":"55","author":"Czernichow","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib1004","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/jama.2018.21442","article-title":"Sprint Mind investigators for the SPRINT Research Group. Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial","volume":"321","author":"Williamson","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib711","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(08)60655-8","article-title":"Global burden of blood-pressure-related disease, 2001","volume":"371","author":"Lawes","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib712","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1001\/archinte.165.16.1896","article-title":"Risk factors for declining ankle-brachial index in men and women 65 years or older: the Cardiovascular Health Study","volume":"165","author":"Kennedy","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib713","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s11606-014-2947-1","article-title":"Characteristics and long-term follow-up of participants with peripheral arterial disease during ALLHAT","volume":"29","author":"Piller","year":"2014","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib714","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1097\/HJH.0b013e3283471151","article-title":"Effect of nebivolol vs. hydrochlorothiazide on the walking capacity in hypertensive patients with intermittent claudication","volume":"29","author":"Diehm","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib715","article-title":"Beta blockers for peripheral arterial disease","volume":"2013","author":"Paravastu","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2025.05.007_bib716","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1161\/HYPERTENSIONAHA.110.169169","article-title":"Beta-blockers in patients with intermittent claudication and arterial hypertension: results from the nebivolol or metoprolol in arterial occlusive disease trial","volume":"58","author":"Espinola-Klein","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib717","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3317\/jraas.2000.002","article-title":"The HOPE study (Heart Outcomes Prevention Evaluation)","volume":"1","author":"Sleight","year":"2000","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.jacc.2025.05.007_bib718","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"Investigators","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib719","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1016\/j.jacc.2024.02.013","article-title":"2024 ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS guideline for the management of lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"83","author":"Gornik","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib720","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101388","article-title":"Determining the frequency and level of task-sharing for hypertension management in LMICs: a systematic review and meta-analysis","volume":"47","author":"Ogungbe","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jacc.2025.05.007_bib721","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/jama.2017.11358","article-title":"Effect of a community health worker-led multicomponent intervention on blood pressure control in low-income patients in Argentina: a randomized clinical trial","volume":"318","author":"He","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib722","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000718","article-title":"Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials","volume":"3","author":"Santschi","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.05.007_bib723","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJMoa1717250","article-title":"A cluster-randomized trial of blood-pressure reduction in black barbershops","volume":"378","author":"Victor","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib724","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1161\/HYP.0000000000000232","article-title":"Implementation strategies to improve blood pressure control in the United States: a scientific statement from the American Heart Association and American Medical Association","volume":"80","author":"Abdalla","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib725","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.117.004386","article-title":"Adapting and evaluating a health system intervention from Kaiser Permanente to improve hypertension management and control in a large network of safety-net clinics","volume":"11","author":"Fontil","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2025.05.007_bib726","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1001\/jama.2013.108769","article-title":"Improved blood pressure control associated with a large-scale hypertension program","volume":"310","author":"Jaffe","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib727","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/jch.13141","article-title":"Measure accurately, Act rapidly, and Partner with patients (MAP) improves hypertension control in medically underserved patients: Care Coordination Institute and American Medical Association Hypertension control project pilot study results","volume":"20","author":"Hanlin","year":"2018","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.jacc.2025.05.007_bib728","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1089\/heq.2022.0109","article-title":"Improvement in hypertension control among adults seen in federally qualified health center clinics in the Stroke Belt: implementing a program with a dashboard and process metrics","volume":"7","author":"Behling","year":"2023","journal-title":"Health Equity"},{"key":"10.1016\/j.jacc.2025.05.007_bib729","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1161\/HYPERTENSIONAHA.118.11558","article-title":"Improving hypertension control in primary care with the Measure Accurately, Act Rapidly, and Partner With Patients (MAP) protocol","volume":"72","author":"Egan","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib730","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib731","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib732","article-title":"Optimal systolic blood pressure target, time to intensification, and time to follow-up in treatment of hypertension: population based retrospective cohort study","volume":"350","author":"Xu","year":"2015","journal-title":"BMJ (Online)"},{"key":"10.1016\/j.jacc.2025.05.007_bib733","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(18)30309-X","article-title":"Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial","volume":"391","author":"McManus","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib734","doi-asserted-by":"crossref","DOI":"10.2196\/42409","article-title":"Electronic health record-driven approaches in primary care to strengthen hypertension management among racial and ethnic minoritized groups in the United States: systematic review","volume":"25","author":"Ose","year":"2023","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.jacc.2025.05.007_bib735","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jamainternmed.2022.3355","article-title":"Effectiveness of standard vs enhanced self-measurement of blood pressure paired with a connected smartphone application: a randomized clinical trial","volume":"182","author":"Pletcher","year":"2022","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib736","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1370\/afm.1665","article-title":"A technology-based quality innovation to identify undiagnosed hypertension among active primary care patients","volume":"12","author":"Rakotz","year":"2014","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib737","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.amjcard.2023.06.109","article-title":"Adding pharmacist-led home blood pressure telemonitoring to usual care for blood pressure control: a systematic review and meta-analysis","volume":"203","author":"Baral","year":"2023","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib738","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/MBP.0b013e328346e092","article-title":"Telecare is a valuable tool for hypertension management, a systematic review and meta-analysis","volume":"16","author":"Verberk","year":"2011","journal-title":"Blood Press Monit"},{"key":"10.1016\/j.jacc.2025.05.007_bib739","first-page":"613","article-title":"Reducing blood pressure with internet-based interventions: a meta-analysis","volume":"29","author":"Liu","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib740","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1001\/jama.2013.6549","article-title":"Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial","volume":"310","author":"Margolis","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib741","article-title":"Home and Online Management and Evaluation of Blood Pressure (HOME BP) using a digital intervention in poorly controlled hypertension: randomised controlled trial","volume":"372","author":"McManus","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2025.05.007_bib742","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/HJH.0b013e32835ca8dd","article-title":"Clinical usefulness and cost effectiveness of home blood pressure telemonitoring: meta-analysis of randomized controlled studies","volume":"31","author":"Omboni","year":"2013","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib743","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/jhh.2016.99","article-title":"Effectiveness of home blood pressure telemonitoring: a systematic review and meta-analysis of randomised controlled studies","volume":"31","author":"Duan","year":"2017","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib744","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1161\/HYPERTENSIONAHA.123.22109","article-title":"Self-measured blood pressure-guided pharmacotherapy: a systematic review and meta-analysis of United States-based telemedicine trials","volume":"81","author":"Acharya","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib745","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.1617","article-title":"Long-term outcomes of the effects of home blood pressure telemonitoring and pharmacist management on blood pressure among adults with uncontrolled hypertension: follow-up of a cluster randomized clinical trial","volume":"1","author":"Margolis","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2025.05.007_bib746","article-title":"Heart disease and stroke prevention:","year":"2024","journal-title":"team-based care to improve blood pressure control"},{"key":"10.1016\/j.jacc.2025.05.007_bib747","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.aogh.2016.02.003","article-title":"Expanding the role of nurses to improve hypertension care and control globally","volume":"82","author":"Himmelfarb","year":"2016","journal-title":"Ann Glob Health"},{"key":"10.1016\/j.jacc.2025.05.007_bib748","article-title":"The Surgeon General's Call to Action to Control Hypertension.","year":"2020","journal-title":"U.S. Department of Health and Human Services, Office of the Surgeon General"},{"key":"10.1016\/j.jacc.2025.05.007_bib749","article-title":"HEARTS Technical package for cardiovascular disease management in primary health care:","year":"2018","journal-title":"team-based care."},{"key":"10.1016\/j.jacc.2025.05.007_bib750","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.amepre.2014.03.004","article-title":"Team-based care and improved blood pressure control: a community guide systematic review","volume":"47","author":"Proia","year":"2014","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib751","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1161\/HYPERTENSIONAHA.120.15946","article-title":"Health care delivery interventions for hypertension management in underserved populations in the United States: a systematic review","volume":"78","author":"Pasha","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib752","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.122.009321","article-title":"Integrating community health workers into community-based primary care practice settings to improve blood pressure control among South Asian immigrants in New York city: results from a randomized control trial","author":"Islam","year":"2023","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2025.05.007_bib753","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002997","article-title":"Effectiveness of a scalable group-based education and monitoring program, delivered by health workers, to improve control of hypertension in rural India: a cluster randomised controlled trial","volume":"17","author":"Gamage","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib754","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/eurjcn\/zvad040","article-title":"Effectiveness of nurse-led interventions versus usual care to manage hypertension and lifestyle behaviour: a systematic review and meta-analysis","volume":"23","author":"Bulto","year":"2024","journal-title":"Eur J Cardiovasc Nurs"},{"key":"10.1016\/j.jacc.2025.05.007_bib755","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1016\/j.jacc.2024.05.034","article-title":"2024 ACC\/AHA key data elements and definitions for social determinants of health in cardiology: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Data Standards","volume":"84","author":"Morris","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib756","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1016\/j.jacc.2015.03.550","article-title":"2015 ACC health policy statement on cardiovascular team-based care and the role of advanced practice providers","volume":"65","author":"Brush","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib757","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.jacc.2015.09.025","article-title":"The role of the clinical pharmacist in the care of patients with cardiovascular disease","volume":"66","author":"Dunn","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib758","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.amepre.2015.04.003","article-title":"Economics of Team-based Care in Controlling Blood Pressure: A Community Guide Systematic Review","volume":"49","author":"Jacob","year":"2015","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib759","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1161\/HYPERTENSIONAHA.122.20810","article-title":"Improved persistence to medication, decreased cardiovascular events and reduced all-cause mortality in hypertensive patients with use of single-pill combinations: results from the START-Study","volume":"80","author":"Schmieder","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib760","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jacc.2018.07.008","article-title":"Prevention and control of hypertension: JACC health promotion series","volume":"72","author":"Carey","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib761","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1111\/jch.13305","article-title":"Home blood pressure telemonitoring in the 21st century","volume":"20","author":"Parati","year":"2018","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.jacc.2025.05.007_bib762","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1097\/HJH.0000000000003202","article-title":"Telemonitoring and protocolized case management for hypertensive community dwelling older adults (TECHNOMED): a randomized controlled trial","volume":"40","author":"Lau","year":"2022","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib763","article-title":"Hypertension management: what is the role of case management?","volume":"51","author":"Ozpancar","year":"2017","journal-title":"Rev Esc Enferm USP"},{"key":"10.1016\/j.jacc.2025.05.007_bib764","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/jch.12803","article-title":"The Kaiser Permanente northern California story: improving hypertension control from 44% to 90% in 13 years (2000 to 2013)","volume":"18","author":"Jaffe","year":"2016","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.jacc.2025.05.007_bib765","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1161\/HYPERTENSIONAHA.120.15873","article-title":"Evidence and recommendations on the use of telemedicine for the management of arterial hypertension: an international expert position paper","volume":"76","author":"Omboni","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib766","doi-asserted-by":"crossref","first-page":"e558","DOI":"10.1161\/CIR.0000000000001107","article-title":"An overview of telehealth in the management of cardiovascular disease: a scientific statement from the American Heart Association","volume":"146","author":"Takahashi","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib767","doi-asserted-by":"crossref","first-page":"E42","DOI":"10.1161\/CIR.0000000000000803","article-title":"Self-measured blood pressure monitoring at home: a joint policy statement from the American Heart Association and American Medical Association","volume":"142","author":"Shimbo","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib768","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1001\/jama.2018.13551","article-title":"Association of blood pressure classification in young adults using the 2017 American College of Cardiology\/American Heart Association blood pressure guideline with cardiovascular events later in life","volume":"320","author":"Yano","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib769","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1177\/1740774514537404","article-title":"The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT)","volume":"11","author":"Ambrosius","year":"2014","journal-title":"Clin Trials"},{"key":"10.1016\/j.jacc.2025.05.007_bib770","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0140-6736(22)02603-4","article-title":"Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial","volume":"401","author":"He","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib771","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","article-title":"Development and validation of the American Heart Association's PREVENT equations","volume":"149","author":"Khan","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib772","doi-asserted-by":"crossref","first-page":"e761","DOI":"10.1016\/S2214-109X(19)30077-4","article-title":"Task sharing with non-physician health-care workers for management of blood pressure in low-income and middle-income countries: a systematic review and meta-analysis","volume":"7","author":"Anand","year":"2019","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.jacc.2025.05.007_bib773","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.gheart.2019.08.003","article-title":"Effect of a community health worker-based approach to integrated cardiovascular risk factor control in India: a cluster randomized controlled trial","volume":"14","author":"Khetan","year":"2019","journal-title":"Glob Heart"},{"key":"10.1016\/j.jacc.2025.05.007_bib774","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1016\/S2214-109X(17)30411-4","article-title":"Effectiveness of a lifestyle intervention led by female community health volunteers versus usual care in blood pressure reduction (COBIN): an open-label, cluster-randomised trial","volume":"6","author":"Neupane","year":"2018","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.jacc.2025.05.007_bib775","doi-asserted-by":"crossref","first-page":"110","DOI":"10.7326\/M17-1805","article-title":"Comparative effectiveness of implementation strategies for blood pressure control in hypertensive patients: a systematic review and meta-analysis","volume":"168","author":"Mills","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib776","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/jan.15159","article-title":"Nurse-led interventions to manage hypertension in general practice: a systematic review and meta-analysis","volume":"78","author":"Stephen","year":"2022","journal-title":"J Adv Nurs"},{"key":"10.1016\/j.jacc.2025.05.007_bib777","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1177\/0897190020903573","article-title":"Pharmacist interventions in the management of blood pressure control and adherence to antihypertensive medications: a systematic review of randomized controlled trials","volume":"34","author":"Reeves","year":"2021","journal-title":"J Pharm Pract"},{"key":"10.1016\/j.jacc.2025.05.007_bib779","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s11606-015-3355-x","article-title":"A successful multifaceted trial to improve hypertension control in primary care: why did it work?","volume":"30","author":"Margolis","year":"2015","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib780","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/nur.21994","article-title":"Nursing case management for people with hypertension in primary health care: a randomized controlled trial","volume":"43","author":"Mattei da Silva","year":"2020","journal-title":"Res Nurs Health"},{"key":"10.1016\/j.jacc.2025.05.007_bib781","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijnurstu.2022.104313","article-title":"The effects of a smartphone-enhanced nurse-facilitated self-care intervention for Chinese hypertensive patients: a randomised controlled trial","volume":"134","author":"Ma","year":"2022","journal-title":"Int J Nurs Stud"},{"key":"10.1016\/j.jacc.2025.05.007_bib782","doi-asserted-by":"crossref","first-page":"e04","DOI":"10.17533\/udea.iee.v39n1e04","article-title":"Effectiveness of nursing case management versus usual care for blood pressure control in adults with hypertension: a systematic review","volume":"39","author":"Mantovanil","year":"2021","journal-title":"Invest Educ Enferm"},{"key":"10.1016\/j.jacc.2025.05.007_bib783","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/jch.12995","article-title":"Measure accurately, Act rapidly, and Partner with patients: An intuitive and practical three-part framework to guide efforts to improve hypertension control","volume":"19","author":"Boonyasai","year":"2017","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.jacc.2025.05.007_bib784","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1001\/jama.299.24.2857","article-title":"Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial","volume":"299","author":"Green","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib785","doi-asserted-by":"crossref","DOI":"10.1161\/HCQ.0000000000000057","article-title":"2019 AHA\/ACC clinical performance and quality measures for adults with high blood pressure: a report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures","volume":"12","author":"Casey","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2025.05.007_bib786","doi-asserted-by":"crossref","DOI":"10.1161\/HCQ.0000000000000103","article-title":"Harnessing mobile health technology for secondary cardiovascular disease prevention in older adults: a scientific statement from the American Heart Association","volume":"14","author":"Schorr","year":"2021","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2025.05.007_bib787","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIR.0000000000000232","article-title":"Current science on consumer use of mobile health for cardiovascular disease prevention: a scientific statement from the American Heart Association","volume":"132","author":"Burke","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib788","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/ajh\/hpab182","article-title":"Proceedings from a National Heart, Lung, and Blood Institute and the Centers for Disease Control and Prevention workshop to control hypertension","volume":"35","author":"Commodore-Mensah","year":"2022","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib789","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/CIR.0000000000001191","article-title":"Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the American Heart Association","volume":"148","author":"Khan","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib790","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib791","first-page":"CD002252","article-title":"Antihypertensive drug therapy for mild to moderate hypertension during pregnancy","volume":"10","author":"Abalos","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2025.05.007_bib792","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1001\/jama.2021.8551","article-title":"Aspirin use to prevent preeclampsia and related morbidity and mortality: updated evidence report and systematic review for the US Preventive Services Task Force","volume":"326","author":"Henderson","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib793","doi-asserted-by":"crossref","DOI":"10.1080\/10641955.2023.2209637","article-title":"Oral nifedipine may be a preferential option for treating acute severe hypertension during pregnancy: a meta-analysis","volume":"42","author":"Ou","year":"2023","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.jacc.2025.05.007_bib794","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/10641955.2022.2056196","article-title":"Different dosage regimens of nifedipine, labetalol, and hydralazine for the treatment of severe hypertension during pregnancy: a network meta-analysis of randomized controlled trials","volume":"41","author":"Wu","year":"2022","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.jacc.2025.05.007_bib795","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3390\/healthcare10020325","article-title":"Antihypertensive medications for severe hypertension in pregnancy: a systematic review and meta-analysis","volume":"10","author":"Awaludin","year":"2022","journal-title":"Healthcare (Basel)"},{"key":"10.1016\/j.jacc.2025.05.007_bib796","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"ACOG practice bulletin, number 222","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jacc.2025.05.007_bib797","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/bmj.327.7421.955","article-title":"Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis","volume":"327","author":"Magee","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2025.05.007_bib798","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa2201295","article-title":"Treatment for mild chronic hypertension during pregnancy","volume":"386","author":"Tita","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib799","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/clc.24013","article-title":"The impact of antihypertensive treatment of mild to moderate hypertension during pregnancy on maternal and neonatal outcomes: an updated meta-analysis of randomized controlled trials","volume":"46","author":"Attar","year":"2023","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib800","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/tera.1420500606","article-title":"Teratogen update: angiotensin-converting enzyme inhibitors","volume":"50","author":"Barr","year":"1994","journal-title":"Teratology"},{"key":"10.1016\/j.jacc.2025.05.007_bib801","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ajog.2020.03.016","article-title":"Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis","volume":"223","author":"Bellos","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jacc.2025.05.007_bib802","first-page":"427","article-title":"Treatment of hypertension in pregnancy: effect of atenolol on maternal disease, preterm delivery, and fetal growth","volume":"98","author":"Easterling","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jacc.2025.05.007_bib803","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/658310","article-title":"The fetal safety of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers","volume":"2012","author":"Moretti","year":"2012","journal-title":"Obstet Gynecol Int"},{"key":"10.1016\/j.jacc.2025.05.007_bib804","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1586\/17512433.2015.1005074","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in women of childbearing age: risks versus benefits","volume":"8","author":"Pucci","year":"2015","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.jacc.2025.05.007_bib805","doi-asserted-by":"crossref","first-page":"585","DOI":"10.15585\/mmwr.mm7117a1","article-title":"Hypertensive disorders in pregnancy and mortality at delivery hospitalization - United States, 2017-2019","volume":"71","author":"Ford","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jacc.2025.05.007_bib806","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.28093","article-title":"Association of birth year of pregnant individuals with trends in hypertensive disorders of pregnancy in the United States, 1995-2019","volume":"5","author":"Cameron","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2025.05.007_bib807","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.023791","article-title":"Trends in the incidence of new-onset hypertensive disorders of pregnancy among rural and urban areas in the United States, 2007 to 2019","volume":"11","author":"Cameron","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.05.007_bib808","doi-asserted-by":"crossref","first-page":"762","DOI":"10.15585\/mmwr.mm6835a3","article-title":"Racial\/ethnic disparities in pregnancy-related deaths - United States, 2007-2016","volume":"68","author":"Petersen","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jacc.2025.05.007_bib809","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020717","article-title":"Trends in prepregnancy obesity and association with adverse pregnancy outcomes in the United States, 2013 to 2018","volume":"10","author":"Wang","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.05.007_bib810","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/AOG.0000000000003021","article-title":"ACOG practice bulletin no.203","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jacc.2025.05.007_bib812","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177554","article-title":"Pre-pregnancy weight status, early pregnancy lipid profile and blood pressure course during pregnancy: the ABCD study","volume":"12","author":"Oostvogels","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2025.05.007_bib813","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1161\/HYPERTENSIONAHA.117.10295","article-title":"Accuracy of blood pressure measurement devices in pregnancy: a systematic review of validation studies","volume":"71","author":"Bello","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib814","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11883-021-00941-4","article-title":"Hypertension in women across the lifespan","volume":"23","author":"Ghazi","year":"2021","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jacc.2025.05.007_bib815","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/AOG.0000000000005613","article-title":"Pregnancy outcomes of nifedipine compared with labetalol for oral treatment of mild chronic hypertension","volume":"144","author":"Sanusi","year":"2024","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jacc.2025.05.007_bib816","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012093","article-title":"Safety of amlodipine in early pregnancy","volume":"8","author":"Mito","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.05.007_bib817","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/10641950701204554","article-title":"Exposure to amlodipine in the first trimester of pregnancy and during breastfeeding","volume":"26","author":"Ahn","year":"2007","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.jacc.2025.05.007_bib818","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.preghy.2023.01.001","article-title":"Risk of major congenital malformations associated with first-trimester antihypertensives, including amlodipine and methyldopa: a large claims database study 2010-2019","volume":"31","author":"Ishikawa","year":"2023","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib819","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.jaad.2018.10.023","article-title":"Lack of evidence for feminization of males exposed to spironolactone in utero: a systematic review","volume":"80","author":"Liszewski","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jacc.2025.05.007_bib820","doi-asserted-by":"crossref","first-page":"R23","DOI":"10.1530\/EJE-14-0444","article-title":"Progress in primary aldosteronism: mineralocorticoid receptor antagonists and management of primary aldosteronism in pregnancy","volume":"172","author":"Riester","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jacc.2025.05.007_bib821","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11154-022-09729-6","article-title":"Primary aldosteronism in pregnancy","volume":"24","author":"Forestiero","year":"2023","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.jacc.2025.05.007_bib822","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1161\/HYPERTENSIONAHA.121.18858","article-title":"Management and outcomes of primary aldosteronism in pregnancy: a systematic review","volume":"79","author":"Sanga","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib824","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1161\/HYP.0000000000000208","article-title":"Hypertension in pregnancy: diagnosis, blood pressure goals, and pharmacotherapy: a scientific statement from the American Heart Association","volume":"79","author":"Garovic","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib826","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"ACOG practice bulletin, number 222","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jacc.2025.05.007_bib827","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S1701-2163(16)30579-5","article-title":"Serious perinatal complications of non-proteinuric hypertension: an international, multicentre, retrospective cohort study","volume":"25","author":"Magee","year":"2003","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jacc.2025.05.007_bib828","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1056\/NEJMoa1404595","article-title":"Less-tight versus tight control of hypertension in pregnancy","volume":"372","author":"Magee","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib829","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1161\/HYPERTENSIONAHA.116.07862","article-title":"The CHIPS randomized controlled trial (Control of Hypertension in Pregnancy Study): is severe hypertension just an elevated blood pressure?","volume":"68","author":"Magee","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib830","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","article-title":"The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice","volume":"27","author":"Magee","year":"2022","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib831","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1097\/AOG.0000000000002708","article-title":"ACOG committee opinion no. 743","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jacc.2025.05.007_bib832","doi-asserted-by":"crossref","first-page":"819","DOI":"10.7326\/M14-1884","article-title":"Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement","volume":"161","author":"LeFevre","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib833","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/jama.2021.14781","article-title":"Aspirin use to prevent preeclampsia and related morbidity and mortality: US Preventive Services Task Force recommendation statement","volume":"326","author":"Force","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib834","article-title":"Pravastatin in preeclampsia: a meta-analysis and systematic review","volume":"9","author":"Meszaros","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jacc.2025.05.007_bib835","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/S0140-6736(18)33212-4","article-title":"Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial","volume":"393","author":"Duhig","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib836","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib837","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1161\/CIRCULATIONAHA.113.003215","article-title":"Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study","volume":"128","author":"Chappell","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib838","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.preghy.2018.05.008","article-title":"Angiogenic biomarkers in triage and risk for preeclampsia with severe features","volume":"13","author":"Rana","year":"2018","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib839","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"ACOG practice bulletin, number 222","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jacc.2025.05.007_bib841","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/CIRCULATIONAHA.123.067597","article-title":"Cardiac remodeling after hypertensive pregnancy following physician-optimized blood pressure self-management: the POP-HT randomized clinical trial imaging substudy","volume":"149","author":"Kitt","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib842","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/HYPERTENSIONAHA.118.10911","article-title":"Self-management of postnatal hypertension: the SNAP-HT trial","volume":"72","author":"Cairns","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib843","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/AOG.0000000000005270","article-title":"Postpartum home blood pressure monitoring: a systematic review","volume":"142","author":"Steele","year":"2023","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jacc.2025.05.007_bib844","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/bmj.39335.385301.BE","article-title":"Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis","volume":"335","author":"Bellamy","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2025.05.007_bib845","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1161\/CIRCULATIONAHA.118.038080","article-title":"Preeclampsia and cardiovascular disease in a large UK pregnancy cohort of linked electronic health records: a CALIBER study","volume":"140","author":"Leon","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib846","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1161\/HYP.0000000000000208","article-title":"Hypertension in pregnancy: diagnosis, blood pressure goals, and pharmacotherapy: a scientific statement from the American Heart Association","volume":"79","author":"Garovic","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib847","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.xjtc.2024.06.003","article-title":"Extending line for minimizing air emboli between perfusion branch and left ventricular vent (ELIZABETH) circuit for minimally invasive cardiac surgery","volume":"26","author":"Nakatsu","year":"2024","journal-title":"JTCVS Tech"},{"key":"10.1016\/j.jacc.2025.05.007_bib848","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1016\/j.jacc.2020.03.060","article-title":"Summary of updated recommendations for primary prevention of cardiovascular disease in women: JACC state-of-the-art review","volume":"75","author":"Cho","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib849","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.jacc.2019.03.010","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"74","author":"Arnett","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib850","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1161\/HYPERTENSIONAHA.122.20018","article-title":"Oral contraceptive pills and hypertension: a review of current evidence and recommendations","volume":"80","author":"Cameron","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib851","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.jacc.2021.02.025","article-title":"Contraception and reproductive planning for women with cardiovascular disease: JACC focus seminar 5\/5","volume":"77","author":"Lindley","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib852","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7304a1","article-title":"U.S. medical eligibility criteria for contraceptive use, 2024","volume":"73","author":"Nguyen","year":"2024","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jacc.2025.05.007_bib853","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1001\/jamainternmed.2023.8555","article-title":"Management of resistant hypertension-an update","volume":"184","author":"Giacona","year":"2024","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib854","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1001\/jamainternmed.2021.6819","article-title":"Prevalence of medications that may raise blood pressure among adults with hypertension in the United States","volume":"182","author":"Vitarello","year":"2022","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib855","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1161\/01.HYP.0000177437.07240.70","article-title":"Non-narcotic analgesic dose and risk of incident hypertension in US women","volume":"46","author":"Forman","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib856","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1056\/NEJM200012213432510","article-title":"The FDA, regulation, and the risk of stroke","volume":"343","author":"Fleming","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib857","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1053\/j.ajkd.2006.11.039","article-title":"Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis","volume":"49","author":"Zhu","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacc.2025.05.007_bib858","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(15)00257-3","article-title":"Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial","volume":"386","author":"Williams","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib859","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/HYPERTENSIONAHA.111.169961","article-title":"Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial","volume":"57","author":"Vaclavik","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib860","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1161\/HYPERTENSIONAHA.117.10662","article-title":"Spironolactone versus clonidine as a fourth-drug therapy for resistant hypertension the REHOT randomized study (Resistant Hypertension Optimal Treatment)","volume":"71","author":"Krieger","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib861","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/CIRCULATIONAHA.107.737957","article-title":"Effect of doxazosin gastrointestinal therapeutic system as third-line antihypertensive therapy on blood pressure and lipids in the Anglo-Scandinavian Cardiac Outcomes Trial","volume":"118","author":"Chapman","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib862","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1053\/j.ajkd.2020.07.018","article-title":"Kidney, cardiac, and safety outcomes associated with alpha-blockers in patients with CKD: a population-based cohort study","volume":"77","author":"Hundemer","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacc.2025.05.007_bib863","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/jch.12847","article-title":"Minoxidil for treatment of resistant hypertension in chronic kidney disease-a retrospective cohort analysis","volume":"18","author":"Mundt","year":"2016","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.jacc.2025.05.007_bib864","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1161\/CIRCULATIONAHA.123.066941","article-title":"Patient-level pooled analysis of endovascular ultrasound renal denervation or a sham procedure 6 months after medication escalation: the RADIANCE clinical trial program","volume":"149","author":"Azizi","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib865","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/S0140-6736(21)00788-1","article-title":"Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial","volume":"397","author":"Azizi","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib866","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1161\/CIRCULATIONAHA.124.069291","article-title":"Effect of alcohol-mediated renal denervation on blood pressure in the presence of antihypertensive medications: primary results from the TARGET BP I randomized clinical trial","volume":"149","author":"Kandzari","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib867","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1161\/HYP.0000000000000084","article-title":"Resistant hypertension: detection, evaluation, and management: a scientific statement from the American Heart Association","volume":"72","author":"Carey","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib868","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.mayocp.2018.12.033","article-title":"Prevalence of apparent treatment-resistant hypertension in the United States according to the 2017 high blood pressure guideline","volume":"94","author":"Patel","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2025.05.007_bib869","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1161\/HYPERTENSIONAHA.123.20894","article-title":"Characterization of individuals with apparent resistant hypertension using contemporary guidelines: insights from CV-QUIC","volume":"80","author":"Ebinger","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib870","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/HYPERTENSIONAHA.118.12191","article-title":"Prevalence of apparent treatment-resistant hypertension in the United States","volume":"73","author":"Carey","year":"2019","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.jacc.2025.05.007_bib871","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/ajh\/hpad084","article-title":"Characteristics and predictors of apparent treatment resistant hypertension in real-world populations using electronic health record-based data","volume":"37","author":"Jafari","year":"2024","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib872","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/HYPERTENSIONAHA.122.20219","article-title":"Social determinants of health and uncontrolled blood pressure in a national cohort of Black and White US adults: the REGARDS study","volume":"80","author":"Akinyelure","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib873","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/eurjpc\/zwad066","article-title":"Apparent treatment-resistant hypertension associated lifetime cardiovascular risk in a longitudinal national registry","volume":"30","author":"Ebinger","year":"2023","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib874","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.3390\/diagnostics13091631","article-title":"Ambulatory resistant hypertension and risk of heart failure in the elderly","volume":"13","author":"Coccina","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.jacc.2025.05.007_bib875","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12882-019-1315-0","article-title":"Resistant hypertension and cardiovascular disease mortality in the US: results from the National Health and Nutrition Examination Survey (NHANES)","volume":"20","author":"Kaczmarski","year":"2019","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.jacc.2025.05.007_bib876","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1161\/HYPERTENSIONAHA.121.18534","article-title":"Nighttime home blood pressure Is associated with the cardiovascular disease events risk in treatment-resistant hypertension","volume":"79","author":"Narita","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib877","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1161\/HYPERTENSIONAHA.121.18064","article-title":"Prognostic impact of home blood pressures for adverse cardiovascular outcomes and mortality in patients with resistant hypertension: a prospective cohort study","volume":"78","author":"Cardoso","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib878","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/S0140-6736(18)31082-1","article-title":"Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial","volume":"391","author":"Azizi","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib879","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1001\/jama.2023.0713","article-title":"Endovascular ultrasound renal denervation to treat hypertension: the RADIANCE II randomized clinical trial","volume":"329","author":"Azizi","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib880","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/S0140-6736(17)32281-X","article-title":"Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial","volume":"390","author":"Townsend","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib881","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.jacc.2023.08.045","article-title":"Safety and efficacy of renal denervation in patients taking antihypertensive medications","volume":"82","author":"Kandzari","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib882","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41440-021-00754-7","article-title":"Catheter-based ultrasound renal denervation in patients with resistant hypertension: the randomized, controlled REQUIRE trial","volume":"45","author":"Kario","year":"2022","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jacc.2025.05.007_bib883","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/HJH.0000000000001584","article-title":"Phase II randomized sham-controlled study of renal denervation for individuals with uncontrolled hypertension-WAVE IV","volume":"36","author":"Schmieder","year":"2018","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib884","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1111\/jcmm.13205","article-title":"Comparison of thiazide-like diuretics versus thiazide-type diuretics: a meta-analysis","volume":"21","author":"Liang","year":"2017","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib885","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/HYPERTENSIONAHA.111.190637","article-title":"Meta-analysis of dose-response relationships for hydrochlorothiazide, chlorthalidone, and bendroflumethiazide on blood pressure, serum potassium, and urate","volume":"59","author":"Peterzan","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib886","article-title":"Chlorthalidone vs hydrochlorothiazide for hypertension treatment after myocardial infarction or stroke: a secondary analysis of a randomized clinical trial","volume":"7","author":"Ishani","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2025.05.007_bib887","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/ckj\/sfac234","article-title":"A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease","volume":"16","author":"Agarwal","year":"2023","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.jacc.2025.05.007_bib888","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/S0140-6736(19)32135-X","article-title":"Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial","volume":"394","author":"Agarwal","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib889","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.HYP.0000259805.18468.8c","article-title":"Effect of spironolactone on blood pressure in subjects with resistant hypertension","volume":"49","author":"Chapman","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib890","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1161\/HYPERTENSIONAHA.114.04019","article-title":"Randomized comparison of renal denervation versus intensified pharmacotherapy including spironolactone in true-resistant hypertension: six-month results from the Prague-15 study","volume":"65","author":"Rosa","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib891","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/jch.12860","article-title":"Add-on use of eplerenone is effective for lowering home and ambulatory blood pressure in drug-resistant hypertension","volume":"18","author":"Eguchi","year":"2016","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.jacc.2025.05.007_bib892","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/jch.12986","article-title":"Low dose-eplerenone treatment decreases aortic stiffness in patients with resistant hypertension","volume":"19","author":"Kalizki","year":"2017","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.jacc.2025.05.007_bib893","doi-asserted-by":"crossref","DOI":"10.1097\/HJH.0000000000001264","article-title":"Low-dose eplerenone decreases left ventricular mass in treatment-resistant hypertension","author":"Schneider","year":"2017","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib894","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S2213-8587(18)30071-8","article-title":"Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies","volume":"6","author":"Williams","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacc.2025.05.007_bib895","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1053\/j.ajkd.2020.07.018","article-title":"Kidney, cardiac, and safety outcomes associated with alpha-blockers in patients with CKD: a population-based cohort study","volume":"77","author":"Hundemer","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacc.2025.05.007_bib896","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/01.CIR.45.3.571","article-title":"Combined therapy with vasodilator drugs and beta-adrenergic blockade in hypertension. A comparative study of minoxidil and hydralazine","volume":"45","author":"Gottlieb","year":"1972","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib897","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(22)02034-7","article-title":"Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial","volume":"400","author":"Schlaich","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib898","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/S0140-6736(20)30554-7","article-title":"Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial","volume":"395","author":"B\u00f6hm","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib899","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1097\/HJH.0000000000001025","article-title":"Spironolactone versus sympathetic renal denervation to treat true resistant hypertension: results from the DENERVHTA study: a randomized controlled trial","volume":"34","author":"Oliveras","year":"2016","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib900","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4244\/EIJ-D-19-00902","article-title":"Review and meta-analysis of renal artery damage following percutaneous renal denervation with radiofrequency renal artery ablation","volume":"16","author":"Townsend","year":"2020","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacc.2025.05.007_bib901","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1161\/HYP.0000000000000240","article-title":"Renal denervation for the treatment of hypertension: a scientific statement from the American Heart Association","volume":"81","author":"Cluett","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib902","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/jamacardio.2023.0338","article-title":"Patient-level pooled analysis of ultrasound renal denervation in the sham-controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO trials","volume":"8","author":"Kirtane","year":"2023","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib903","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1016\/j.jcin.2021.09.020","article-title":"Renal denervation for hypertension: a systematic review and meta-analysis of randomized, blinded, placebo-controlled trials","volume":"14","author":"Ahmad","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2025.05.007_bib904","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41440-021-00761-8","article-title":"Effects of renal denervation on blood pressures in patients with hypertension: a systematic review and meta-analysis of randomized sham-controlled trials","volume":"45","author":"Ogoyama","year":"2022","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jacc.2025.05.007_bib905","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jacc.2013.04.010","article-title":"Effectiveness of renal denervation therapy for resistant hypertension: a systematic review and meta-analysis","volume":"62","author":"Davis","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib906","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib907","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/HYPERTENSIONAHA.108.189141","article-title":"Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research","volume":"51","author":"Calhoun","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib908","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/HYPERTENSIONAHA.118.11337","article-title":"Hypertension treatment effects on orthostatic hypotension and its relationship with cardiovascular disease","volume":"72","author":"Juraschek","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib909","doi-asserted-by":"crossref","first-page":"58","DOI":"10.7326\/M20-4298","article-title":"Effects of intensive blood pressure treatment on orthostatic hypotension: a systematic review and individual participant-based meta-analysis","volume":"174","author":"Juraschek","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib910","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/HYPERTENSIONAHA.119.14309","article-title":"Orthostatic hypotension, cardiovascular outcomes, and adverse events: results from SPRINT","volume":"75","author":"Juraschek","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib911","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1001\/jama.2016.7050","article-title":"Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged \u226575 years: a randomized clinical trial","volume":"315","author":"Williamson","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib912","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0298435","article-title":"Orthostatic hypotension in stroke\/TIA patients: Association with new events and the effect of the NAILED intervention","volume":"19","author":"Ogren","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2025.05.007_bib913","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/ageing\/afp192","article-title":"The association between orthostatic hypotension and medication use in the British Women's Heart and Health study","volume":"39","author":"Kamaruzzaman","year":"2010","journal-title":"Age Ageing"},{"key":"10.1016\/j.jacc.2025.05.007_bib914","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jash.2016.08.005","article-title":"Orthostatic changes in systolic blood pressure among SPRINT participants at baseline","volume":"10","author":"Townsend","year":"2016","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib915","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1161\/01.HYP.19.6.508","article-title":"Orthostatic hypotension in older adults. The Cardiovascular Health Study. CHS Collaborative Research Group","volume":"19","author":"Rutan","year":"1992","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib916","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/HYPERTENSIONAHA.110.161844","article-title":"Postural changes in blood pressure and incidence of ischemic stroke subtypes: the ARIC study","volume":"57","author":"Yatsuya","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib917","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/eurheartj\/ehp329","article-title":"Orthostatic hypotension predicts all-cause mortality and coronary events in middle-aged individuals (The Malmo Preventive Project)","volume":"31","author":"Fedorowski","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.05.007_bib918","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/jhh.2014.130","article-title":"Orthostatic hypotension in a cohort of hypertensive patients referring to a hypertension clinic","volume":"29","author":"Di Stefano","year":"2015","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib919","first-page":"969","article-title":"Double-blind comparison of doxazosin, nadolol and placebo in patients with mild-to-moderate hypertension","volume":"43","author":"Svetkey","year":"1988","journal-title":"Curr Ther Res"},{"key":"10.1016\/j.jacc.2025.05.007_bib920","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1185\/03007998809114241","article-title":"Loop diuretics cause less postural hypotension than thiazide diuretics in the frail elderly","volume":"11","author":"Heseltine","year":"1988","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jacc.2025.05.007_bib921","first-page":"1061","article-title":"Postural hypotension and mental function in the elderly","volume":"119","author":"Myers","year":"1978","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.jacc.2025.05.007_bib922","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146156","article-title":"Single agent antihypertensive therapy and orthostatic blood pressure behaviour in older adults using beat-to-beat measurements: the Irish Longitudinal Study on Ageing","volume":"11","author":"Canney","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2025.05.007_bib923","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3949\/ccjm.77a.09118","article-title":"Preventing and treating orthostatic hypotension: as easy as A, B, C","volume":"77","author":"Figueroa","year":"2010","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib924","doi-asserted-by":"crossref","first-page":"430","DOI":"10.7326\/M16-1785","article-title":"Pharmacologic treatment of hypertension in adults aged 60 years or older to higher versus lower blood pressure targets: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians","volume":"166","author":"Qaseem","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib925","first-page":"e282","article-title":"Effectiveness of blood pressure-lowering intervention on risk of total dementia among patients with hypertension: a cluster-randomized effectiveness trial. Abstract #23343","volume":"148","author":"He","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib926","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s12028-021-01417-8","article-title":"Comparison of intravenous antihypertensives on blood pressure control in acute neurovascular emergencies: a systematic review","volume":"37","author":"Brown","year":"2022","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.jacc.2025.05.007_bib927","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ahj.2013.12.023","article-title":"Clevidipine in acute heart failure: results of the study of blood pressure control in acute heart failure-a pilot study (PRONTO)","volume":"167","author":"Peacock","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2025.05.007_bib928","first-page":"CD003653","article-title":"Pharmacological interventions for hypertensive emergencies","volume":"2008","author":"Perez","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2025.05.007_bib929","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1161\/CIRCULATIONAHA.121.056546","article-title":"Blood pressure, hypertension, and the risk of aortic dissection incidence and mortality: results from the J-SCH Study, the UK Biobank Study, and a meta-analysis of cohort studies","volume":"145","author":"Hibino","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib930","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1161\/HYPERTENSIONAHA.123.21902","article-title":"Cardiovascular complications in pheochromocytoma and paraganglioma: does phenotype matter?","volume":"81","author":"Petrak","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib931","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1001\/jamaneurol.2020.3075","article-title":"Outcomes of intensive systolic blood pressure reduction in patients with intracerebral hemorrhage and excessively high initial systolic blood pressure: post hoc analysis of a randomized clinical trial","volume":"77","author":"Qureshi","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jacc.2025.05.007_bib932","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1161\/STROKEAHA.120.030272","article-title":"Systolic blood pressure reduction and acute kidney injury in intracerebral hemorrhage","volume":"51","author":"Qureshi","year":"2020","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2025.05.007_bib933","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jamainternmed.2023.1667","article-title":"Clinical outcomes of intensive inpatient blood pressure management in hospitalized older adults","volume":"183","author":"Anderson","year":"2023","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib934","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1751-7133.2009.00133.x","article-title":"Clevidipine for severe hypertension in acute heart failure: a VELOCITY trial analysis","volume":"16","author":"Peacock","year":"2010","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.jacc.2025.05.007_bib935","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/ajh\/hpad112","article-title":"Correlates of spontaneous blood pressure reduction following severe inpatient hypertension development","volume":"37","author":"Garg","year":"2023","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib936","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1161\/HYPERTENSIONAHA.121.17279","article-title":"Pro re nata antihypertensive medications and adverse outcomes in hospitalized patients: a propensity-matched cohort study","volume":"78","author":"Mohandas","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.05.007_bib937","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.029355","article-title":"Clinical outcomes in hypertensive emergency: a systematic review and meta-analysis","volume":"12","author":"Siddiqi","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.05.007_bib938","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1097\/HJH.0000000000002961","article-title":"Cardiovascular prognosis in patients admitted to an emergency department with hypertensive emergencies and urgencies","volume":"39","author":"Paini","year":"2021","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib939","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1161\/CIR.0000000000001106","article-title":"2022 ACC\/AHA guideline for the diagnosis and management of aortic disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"146","author":"Isselbacher","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.007_bib940","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib941","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib942","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.jsxm.2016.06.014","article-title":"Blood pressure, sexual activity, and dysfunction in women with hypertension: baseline findings from the Systolic Blood Pressure Intervention Trial (SPRINT)","volume":"13","author":"Foy","year":"2016","journal-title":"J Sex Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib943","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jsxm.2018.12.007","article-title":"Blood pressure, sexual activity, and erectile function in hypertensive men: baseline findings from the Systolic Blood Pressure Intervention Trial (SPRINT)","volume":"16","author":"Foy","year":"2019","journal-title":"J Sex Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib944","doi-asserted-by":"crossref","first-page":"e12644","DOI":"10.1111\/and.12644","article-title":"Hypertension might be a risk factor for erectile dysfunction: a meta-analysis","volume":"49","author":"Ning","year":"2017","journal-title":"Andrologia"},{"key":"10.1016\/j.jacc.2025.05.007_bib945","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11920-996-0006-2","article-title":"Prevalence and risk factors of sexual dysfunction in men and women","volume":"2","author":"Rosen","year":"2000","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.jacc.2025.05.007_bib946","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11906-019-0925-z","article-title":"Sexual dysfunction in women with hypertension: a systematic review and meta-analysis","volume":"21","author":"Santana","year":"2019","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.jacc.2025.05.007_bib947","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1097\/HJH.0000000000000911","article-title":"Antihypertensive medications and sexual function in women: baseline data from the SBP intervention trial (SPRINT)","volume":"34","author":"Thomas","year":"2016","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib949","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/009262300278597","article-title":"The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function","volume":"26","author":"Rosen","year":"2000","journal-title":"J Sex Marital Ther"},{"key":"10.1016\/j.jacc.2025.05.007_bib950","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0090-4295(97)00238-0","article-title":"The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction","volume":"49","author":"Rosen","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.jacc.2025.05.007_bib951","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1097\/HJH.0000000000002382","article-title":"Update of the position paper on arterial hypertension and erectile dysfunction","volume":"38","author":"Viigimaa","year":"2020","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib952","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1524-6175.2005.05285.x","article-title":"The effect of antihypertensive drugs on erectile function: a proposed management algorithm","volume":"8","author":"Doumas","year":"2006","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.jacc.2025.05.007_bib953","first-page":"47","article-title":"Sexual dysfunction as an obstacle to compliance with antihypertensive therapy","volume":"1","author":"Rosen","year":"1997","journal-title":"Blood Press Suppl"},{"key":"10.1016\/j.jacc.2025.05.007_bib954","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.amjhyper.2003.08.016","article-title":"Effect of valsartan and atenolol on sexual behavior in hypertensive postmenopausal women","volume":"17","author":"Fogari","year":"2004","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib955","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1097\/01.hjh.0000251898.40002.5b","article-title":"Female sexual dysfunction in essential hypertension: a common problem being uncovered","volume":"24","author":"Doumas","year":"2006","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib956","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jchf.2015.03.008","article-title":"Effects of beta-blocker withdrawal in acute decompensated heart failure: a systematic review and meta-analysis","volume":"3","author":"Prins","year":"2015","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacc.2025.05.007_bib957","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.117.004356","article-title":"Clinical events after discontinuation of \u03b2-blockers in patients without heart failure optimally treated after acute myocardial infarction","volume":"11","author":"Neumann","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2025.05.007_bib958","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJMoa041895","article-title":"Perioperative beta-blocker therapy and mortality after major noncardiac surgery","volume":"353","author":"Lindenauer","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib959","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1067\/mhj.2001.111547","article-title":"Perioperative beta-blocker withdrawal and mortality in vascular surgical patients","volume":"141","author":"Shammash","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2025.05.007_bib960","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1001\/jamainternmed.2013.11349","article-title":"Association of beta-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study","volume":"174","author":"Andersson","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib961","doi-asserted-by":"crossref","first-page":"661","DOI":"10.12788\/jhm.3036","article-title":"Prospective randomized evaluation of preoperative angiotensin-converting enzyme inhibition (PREOP-ACEI)","volume":"13","author":"Shiffermiller","year":"2018","journal-title":"J Hosp Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib962","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1213\/ANE.0000000000002837","article-title":"A systematic review of outcomes associated with withholding or continuing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers before noncardiac surgery","volume":"127","author":"Hollmann","year":"2018","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jacc.2025.05.007_bib963","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/eurheartj\/ehad716","article-title":"Discontinuation vs. continuation of renin-angiotensin system inhibition before non-cardiac surgery: the SPACE trial","volume":"45","author":"Ackland","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.05.007_bib964","doi-asserted-by":"crossref","first-page":"605","DOI":"10.7326\/M22-3157","article-title":"Hypotension-avoidance versus hypertension-avoidance strategies in noncardiac surgery: (POISE-3) an international randomized controlled trial","volume":"176","author":"Marcucci","year":"2023","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib965","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/ALN.0000000000001404","article-title":"Withholding versus continuing angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers before noncardiac surgery: an analysis of the vascular events in noncardiac surgery patients cohort evaluation prospective cohort","volume":"126","author":"Roshanov","year":"2017","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jacc.2025.05.007_bib966","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1097\/HJH.0000000000001771","article-title":"The association between preinduction arterial blood pressure and postoperative cardiovascular, renal, and neurologic morbidity, and in-hospital mortality in elective noncardiac surgery: an observational study","volume":"36","author":"Abdelmalak","year":"2018","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.05.007_bib967","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/bja\/aeh091","article-title":"Hypertension, hypertensive heart disease and perioperative cardiac risk","volume":"92","author":"Howell","year":"2004","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jacc.2025.05.007_bib968","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.287.16.2043","article-title":"Preoperative evaluation of the patient with hypertension","volume":"287","author":"Fleisher","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.007_bib969","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1056\/NEJMoa1401106","article-title":"Clonidine in patients undergoing noncardiac surgery","volume":"370","author":"Devereaux","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib970","article-title":"Perioperative beta-blockers for preventing surgery-related mortality and morbidity in adults undergoing non-cardiac surgery","volume":"9","author":"Blessberger","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2025.05.007_bib971","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1001\/archinte.1981.00340090021007","article-title":"Withdrawal syndromes and the cessation of antihypertensive therapy","volume":"141","author":"Hart","year":"1981","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib972","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00000658-198911000-00012","article-title":"The preoperative and intraoperative hemodynamic predictors of postoperative myocardial infarction or ischemia in patients undergoing noncardiac surgery","volume":"210","author":"Charlson","year":"1989","journal-title":"Ann Surg"},{"issue":"Suppl 1","key":"10.1016\/j.jacc.2025.05.007_bib973","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1111\/j.1540-8191.2006.00214.x","article-title":"Exploring an optimum intra\/postoperative management strategy for acute hypertension in the cardiac surgery patient","volume":"21","author":"Cheung","year":"2006","journal-title":"J Card Surg"},{"key":"10.1016\/j.jacc.2025.05.007_bib974","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/bja\/86.6.789","article-title":"Survey of cancellation rate of hypertensive patients undergoing anaesthesia and elective surgery","volume":"86","author":"Dix","year":"2001","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jacc.2025.05.007_bib975","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1093\/ajhp\/61.16.1661","article-title":"Acute postoperative hypertension: a review of therapeutic options","volume":"61","author":"Haas","year":"2004","journal-title":"Am J Health Syst Pharm"},{"issue":"19","key":"10.1016\/j.jacc.2025.05.007_bib976","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.jacc.2024.06.013","article-title":"2024 AHA\/ACC\/ACS\/ASNC\/HRS\/SCA\/SCCT\/SCMR\/SVM guideline for perioperative cardiovascular management for noncardiac surgery: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"84","author":"Thompson","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib977","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jclinane.2017.09.004","article-title":"Optimal blood pressure decreases acute kidney injury after gastrointestinal surgery in elderly hypertensive patients: a randomized study: optimal blood pressure reduces acute kidney injury","volume":"43","author":"Wu","year":"2017","journal-title":"J Clin Anesth"},{"key":"10.1016\/j.jacc.2025.05.007_bib978","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12871-018-0487-7","article-title":"Consequences of continuing renin angiotensin aldosterone system antagonists in the preoperative period: a systematic review and meta-analysis","volume":"18","author":"Ling","year":"2018","journal-title":"BMC Anesthesiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib979","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1001\/archinte.1997.00440420033005","article-title":"The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure","volume":"157","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2025.05.007_bib980","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0025-7125(16)30256-5","article-title":"Is blood pressure control necessary before surgery?","volume":"77","author":"Wolfsthal","year":"1993","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.jacc.2025.05.007_bib981","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00000542-197904000-00002","article-title":"Risks of general anesthesia and elective operation in the hypertensive patient","volume":"50","author":"Goldman","year":"1979","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jacc.2025.05.007_bib982","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/ANA.0b013e31827a0151","article-title":"An observational study of the influence of \"white-coat hypertension\" on day-of-surgery blood pressure determinations","volume":"25","author":"Drummond","year":"2013","journal-title":"J Neurosurg Anesthesiol"},{"key":"10.1016\/j.jacc.2025.05.007_bib983","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.cardfail.2014.04.013","article-title":"Can medications be safely withdrawn in patients with stable chronic heart failure? Systematic review and meta-analysis","volume":"20","author":"Hopper","year":"2014","journal-title":"J Card Fail"},{"key":"10.1016\/j.jacc.2025.05.007_bib984","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/S0140-6736(08)60601-7","article-title":"Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial","volume":"371","author":"Devereaux","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.007_bib985","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/BF00432025","article-title":"Catecholamine metabolism during clonidine withdrawal","volume":"84","author":"Martin","year":"1984","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jacc.2025.05.007_bib986","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/bmj.38503.623646.8F","article-title":"How strong is the evidence for the use of perioperative beta blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials","volume":"331","author":"Devereaux","year":"2005","journal-title":"BMJ"}],"updated-by":[{"DOI":"10.1016\/j.jacc.2025.10.006","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000}},{"DOI":"10.1016\/j.jacc.2026.04.021","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000}}],"container-title":["JACC"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109725064800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109725064800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T02:49:37Z","timestamp":1793760577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109725064800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":989,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0735109725064800"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2025.05.007","relation":{"is-referenced-by":[{"id-type":"doi","id":"10.1007\/s12170-026-00787-y","asserted-by":"object"}]},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2025 AHA\/ACC\/AANP\/AAPA\/ABC\/ACCP\/ACPM\/AGS\/AMA\/ASPC\/NMA\/PCNA\/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults","name":"articletitle","label":"Article Title"},{"value":"JACC","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2025.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Heart Association, Inc. and the American College of Cardiology Foundation","name":"copyright","label":"Copyright"}]}}